PYRIMIDINE UREA COMPOUND CONTAINING ISOXAZOLINES AND USE THEREOF

Information

  • Patent Application
  • 20180230139
  • Publication Number
    20180230139
  • Date Filed
    December 14, 2015
    8 years ago
  • Date Published
    August 16, 2018
    5 years ago
Abstract
The present invention relates to herbicide. Specifically to a kind of uracil compounds containing isoxazoline ring and the uses thereof. The present invention compounds have very good herbicidal activity, can effectively control weeds, such as Echinochloa crusgalli, Setaria viridis, Cyperus difformis, Juncellus serotinus, Digitaria sangunalis, Arthraxon hispidus, Abutilon theophrasti, Zinnia elegans, Amaranthus retrofluxes, Portulaca oleracea, Xanthium sibiricum, Solanum nigrum, Cassia tora, Hibiscus trionum, Glycine soja, an so on. They can effectively control weeds even at lower doses. The present invention compounds also safe to wheats, corns and rices, and can used as herbicides in agriculture fields.
Description
FIELD OF THE INVENTION

The present invention relates to herbicide. Specifically to a kind of uracil compounds containing isoxazoline ring and the uses thereof.


BACKGROUND OF THE INVENTION

The research of uracil derivatives as herbicides began in the 1960s and peaked in the 1990s. Although the development of uracil herbicides were seldom reported, some patents of uracil derivatives were often disclosed. Isagro Ricerca disclosed the following general formula in WO2004056785. However, the herbicidal properties of these known compounds are not always entirely satisfactory.




embedded image


Wherein: Q1 was 5-membered heterocycle such as oxazolyl, thiazolyl, benzoxazolyl, benzothienyl, benzothiazolyl, etc. Q2 was F or H.


Even though some similarity can be observed between published compounds in the prior art and the present invention compounds, the compounds having the structure of general formula (I) were different significantly from those in prior art, and have good herbicidal activity as well.


SUMMARY OF THE INVENTION

In order to discover and develop new herbicides for solving the increasing problem of resistance, the present invention provides a kind of uracil compounds containing isoxazoline ring and the uses thereof.


In order to achieve the above object, technical solution of the present invention is as follows:


The present invention provides a kind of uracil compounds containing isoxazoline ring having general formula (I):




embedded image


Wherein:

R1, R2 are selected from C1-C6alkyl or C1-C6haloalkyl;


R3, R4, R5, R6 are selected from H, halogen, C1-C6alkyl, C1-C6alkoxy, C1-C6haloalkoxy, C1-C6alkylthio or C1-C6alkylsulfonyl;


R7, R8 are selected from H, CN, C1-C6alkyl, CO2R11, CH2OR12, phenyl, or phenyl substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C8alkyl, C1-C8haloalkyl, C1-C8alkoxy, C1-C8haloalkoxy, C1-C8alkoxycarbonyl, C1-C8alkylthio or C1-C8alkylsulfonyl;


R9, R10 are selected from H, CN, C1-C6alkyl, C1-C6haloalkyl, CO2R11, CH2OR12, CH2NR13R14, CONR13R14, phenyl, or phenyl substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy, C1-C4haloalkoxy, C1-C4alkoxycarbonyl, C1-C4alkylthio or C1-C4alkylsulfonyl;


R11 is selected from H, C1-C6alkyl, C1-C6haloalkyl, C3-C6alkenyl, C3-C6alkynyl, C1-C6alkoxyC1-C6alkyl, C1-C6alkoxycarbonylC2-C4alkyl, unsubstituted or substituted following groups: benzyl, furanmethyl, thiazolemethyl, tetrahydrofuranmethyl or pyridinemethyl, which is mutually independently optionally substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C8alkyl, C1-C8haloalkyl, C1-C8alkoxy, C1-C8haloalkoxy, C1-C8alkoxycarbonyl, C1-C8alkylthio or C1-C8alkylsufonyl;


R12 is selected from H, C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxycarbonyl, C1-C6alkylcarbonyl, C1-C6haloalkylcarbonyl, C3-C6cycloalkylcarbonyl, C3-C6halocycloalkylcarbonyl, C1-C6alkylsulfonyl, C1-C6haloalkylsulfonyl, C1-C6alkylaminosulfonyl, di(C1-C6)alkylaminosulfonyl, C1-C6alkylaminocarbonyl, di(C1-C6)alkylaminocarbonyl, di(C1-C6)alkylaminothiocarbonyl, C1-C6alkylthioC2-C6alkylcarbonyl. R12 is also selected from unsubstituted or substituted following groups: phenyl, phenylC1-C2alkyl, phenylC2-C4alkenyl, phenylcarbonyl, phenylC1-C2alkylcarbonyl, phenoxyC1-C2alkylcarbonyl, phenylC2-C4alkenylcarbonyl, heteroaryl, heteroarylC1-C2alkyl or heteroarylcarbonyl, which is mutually independently optionally substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy, C1-C4haloalkoxy, C1-C4alkoxycarbonyl; C1-C4alkylthio, C1-C4alkylsulfonyl, or phenoxy substituted with 1-4substitutents selected from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy or C1-C4haloalkoxy;


R13, R14 are selected from H, C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxycarbonylC1-C6alkyl; or R13 joined together with R14 through N to form five or six membered ring.


The preferred compounds of general formula (I) of this invention are:


R1 is selected from C1-C4haloalkyl;


R2 is selected from C1C4alkyl or C1-C4haloalkyl;


R3, R4, R5, R6 are selected from H, halogen, C1-C6alkyl or C1-C6alkoxy;


R7 is selected from H or C1-C6alkyl;


R8 is selected from H, C1-C6alkyl, CO2R11 or CH2OR12;


R9 is selected from H, CN, C1-C6alkyl, C1-C6haloalky, CO2R11, CH2OR12, CH2NR13R14 or CONR13R14;


R10 is selected from H, C1-C6alkyl, C1-C6haloalkyl, phenyl, or phenyl substituted with 1-4substitutents selected from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy, C1-C4haloalkoxy, C1-C4alkoxycarbonyl, C1-C4alkylthio or C1-C4alkylsulfonyl;


R11 is selected from H, C1-C6alkyl, C1-C6haloalkyl, C3-C4alkenyl, C3-C4alkynyl, C1-C4alkoxyC1-C4alkyl, C1-C4alkoxycarbonylC2-C3alkyl, unsubstituted or substitutued following groups: benzyl, furanmethyl, or tetrahydrofuranmethyl, which is mutually independently optionally substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C6alkyl or C1-C6haloalkyl;


R12 is selected from H, C1-C6alkyl, C1-C6haloalkyl, C1-C6alkoxycarbonyl, C1-C6alkylcarbonyl, C1-C6haloalkylcarbonyl, C3-C6cycloalkylcarbonyl, C3-C6halocycloalkylcarbonyl, C1-C6alkylsulfonyl, C1-C6haloalkylsulfonyl, C1-C6alkylaminosulfonyl, di(C1-C6)alkylaminosulfonyl, C1-C6alkylaminocarbonyl, di(C1-C6)alkylaminocarbonyl, di(C1-C6)alkylaminothiocarbonyl, C1-C6alkylthioC2-C6alkylcarbonyl. R12 is also selected from unsubstituted or substituted following groups: phenylC1-C2alkyl, phenylcarbonyl, phenylC1-C2alkylcarbonyl, phenoxyC1-C2alkylcarbonyl, phenylC2-C4alkenylcarbonyl, thiophenylcarbonyl, pyrazolcarbonyl or quinolinecarbonyl, which is mutually independently optionally substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy, C1-C4haloalkoxy, C1-C4alkoxycarbonyl, C1-C4alkylthio, C1-C4alkylsulfonyl, or phenoxy substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy or C1-C4haloalkoxy;


R13, R14 are selected from H, C1-C4alkyl, C1-C4haloalkyl or C1-C4alkoxycarbonylC1-C4alkyl; or R13 joined together with R14 through N to form five or six membered ring.


Furthermore, the preferred compounds of general formula (I) of this invention are:


R1 is CF3;


R2 is CH3;


R3, R4, R5, R6 are selected from H, halogen or C1-C4alkyl;


R7 is selected from H or C1-C4alkyl;


R8 is selected from H, C1-C4alkyl, CO2R11 or CH2OR12;


R9 is selected from H, CN, C1-C4alkyl, C1-C4haloalkyl, CO2R11, CH2OR12, CH2NR13R14 or CONR13R14;


R10 is selected from H, C1-C4alkyl, C1-C4haloalkyl, phenyl, or phenyl substituted with 1-4 substitutents selected, from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy, C1-C4haloalkoxy, C1-C4alkoxycarbonyl, C1-C4alkylthio or C1-C4alkylsulfonyl;


R11 is selected from H, C1-C4alkyl, C1-C4haloalkyl, C3-C4alkenyl, C3-C4alkynyl, C1-C4alkoxyC1-C4alkyl, C1-C4alkoxycarbonylC2-C3alkyl, unsubstituted or substituted following groups; benzyl, furanmethyl, or tetrahydrofuranmethyl, which is mutually independently optionally substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C4alkyl or C1-C4haloalkyl;


R12 is selected from H, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxycarbonyl, C1-C4alkylcarbonyl, C1-C4haloalkylcarbonyl, C3-C6cycloalkylcarbonyl, C3-C6halocycloalkylcarbonyl, C1-C4alkylsulfonyl, C1-C4haloalkylsulfonyl, C1-C3alkylaminosulfonyl, di(C1C3)alkylaminosulfonyl, C1-C3alkylaminocarbonyl, di(C1-C3 )alkylaminocarbonyl, di(C1-C3alkylaminothiocarbonyl, C1-C2alkylthioC2-C4alkylcarbonyl. R12 is also selected from unsubstituted or substituted following groups; phenylC1-C2alkyl, phenylcarbonyl, phenylC1-C2alkylcarbonyl, phenoxyC1-C2alkylcarbonyl, phenylC2-C4alkenylcarbonyl, thiophenylcarbonyl, pyrazolcarbonyl or quinolinecarbonyl, which is mutually independently optionally substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy, C1-C4haloalkoxy, C1-C4alkoxycarbonyl, C1-C4alkylthio, C1-C4alkylsulfonyl, or phenoxy substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy or C1-C4haloalkoxy;


R13, R14 are selected from H, C1-C4alkyl, C1-C4haloalkyl or C1-C4alkoxycarbonylC1-C4alkyl; or R13 joined together with R14 through N to form five or six membered ring.


Even more preferred compounds of formula (I) of this invention are:


R1 is CF3;


R2 is CH3;


R3, R4, R5, R6 are selected from H, F, Cl or CH3;


R7 is selected from H or CH3;


R8 is selected from H, CH3, CO2R11 or CH2OR12;


R9 is selected from H, CN, CH3, C2H5, CH2Cl, CH2Br, CO2R11, CH2OR12, CH2NR13R14 or CONR13R14;


R10 is selected from H, C1-C4alkyl, C1-C4haloalkyl, phenyl, or phenyl substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy or C1-C4haloalkoxy;


R11 is selected from H, C1-C4alkyl, C1-C4haloalkyl, allyl, propargyl, C1-C3alkoxyC1-C3alkyl, C1-C4alkoxycarbonylC2-C3alkyl, unsubstituted or substituted following groups: benzyl, furanmethyl, or tetrahydrofuranmethyl, or above benzyl, furanmethyl and tetrahydrofuranmethyl which is mutually independently optionally substituted with 1-4 substitutents selected from halogen, CN, NO2 or C1-C4alkyl;


R12 is selected from H, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxycarbonyl, C1-C4alkylcarbonyl, C1-C4haloalkylcarbonyl, C3-C6cycloalkylcarbonyl, C1-C4alkylsulfonyl, C1-C4haloalkylsulfonyl, di(C1-C3)alkylaminosulfonyl, C1-C3alkylaminocarbonyl, di(C1-C3)alkylaminocarbonyl, di(C1-C3)alkylaminothiocarbonyl, C1-C2alkylthioC2-C4alkylcarbonyl. R12 is also selected from unsubstituted or substituted following groups: phenylcarbonyl, phenylC1-C2alkylcarbonyl, phenoxyC1-C2alkylcarbonyl, thiophenylcarbonyl, pyrazolcarbonyl or quinolinecarbonyl, which is mutually independently optionally substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy, C1-C4haloalkoxy, C1-C4alkoxycarbonyl, C1-C4alkylthio, C1-C4alkylsulfonyl or 2-chloro-4-trifluoromethyl-phenoxy;


R13, R14 are selected from H, C1-C4alkyl, C1-C4haloalkyl or C1-C4alkoxycarbonylC1-C4alkyl; or R13 joined together with R14 through N to form five or six membered ring.


Even more compounds of general formula (I) of the invention are;


R1 is CF3;


R2 is CH3;


R3, R4 are selected from H, F, Cl or CH3;


R5, R6 are H;


R7 is selected from H or CH3;


R8 is selected from H, CH3, CO2R11 or CH2OR2;


R9 is selected from H, CN, CH3, C2H5, CH2Cl, CH2Br, CO2R11, CH2OR12 or CONR13R14;


R8, R9 are not selected from CO2R11 or CH2OR12 at the same;


R10 is selected from H, CH3, C2H5, CF3, CHF2, phenyl, or phenyl substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy or C1-C4haloalkoxy;


R11 is selected from H, CH3, C2H5, CH3CH2CH2, CH3CH2CH2CH2, (CH3)2CH, (CH3)2CHCH2, (CH3)3C, CF3CH2, allyl, propargyl, CH3OCH2CH2, C2H5OCH2CH2, CH3CO2CH2CH2 or tetrahydrofuranmethyl;


R12 is selected from H, C1-C4alkoxycarbonyl, C1-C4alkylcarbonyl, C1-C4haloalkylcarbonyl, C3-C6cycloalkylcarbonyl, C1-C4alkylsulfonyl, C1-C4haloalkylsulfonyl, di(C1-C2)alkylaminosulfonyl, C1-C2alkylaminocarbonyl, di(C1-C3)alkylaminocarbonyl, di(C1-C2)alkylaminothiocarbonyl, C1-C2alkylthioC2-C4alkylcarbonyl. R12 is also selected from unsubstituted or substituted following groups: phenylcarbonyl, phenylC1-C2alkylcarbonyl, phenoxyC1-C2alkylcarbonyl, thiophenylcarbonyl or quinolinecarbonyl, which is mutually independently optionally substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy, C1-C4haloalkoxy, C1-C4alkoxycarbonyl, C1-C4alkylthio, C1-C4alkylsulfonyl or 2-chloro-4-trifluoromethyl-phenoxy;


R13 is selected from H, C1-C4alkyl or C1-C4haloalkyl;


R14 is selected from H, C1-C4alkyl or C1-C4alkoxycarbonylC1-C4alkyl;


or R13 joined together with R14 through N to form five or six membered ring.


Even more compounds of general formula (I) of the invention are:


R1 is CF3;


R2 is CH3;


R3, R4 are selected from H, F or Cl;


R5, R6, are H;


R7 is selected from H or CH3:


R8 is selected from H, CH3, CO2R11 or CH2OR12;


R9 is selected from H, CN, CH3, C2H5, CH2Cl, CH2Br, CO2R11, CH2OR12 or CONR13R14;


R8, R9 are not selected from CO2R11 or CH2OR12 at the same;


R10 is selected from H, CH3 or C2H5;


R11 is selected from H, CH3, C2H5, CH3CH2CH2, CH3CH2CH2CH2, (CH3)2CH, (CH3)2CHCH2, (CH3)3C, CF3CH2, allyl, propargyl, CH3OCH2CH2, CH2H5OCH2CH2, CH3CO2CH2CH2 or tetrahydrofuranmethyl;


R12 is selected from H, C1-C4alkylcarbonyl, C1-C4haloalkylcarbonyl, C3-C6cycloalkylcarbonyl, C1-C4alkylsulfonyl, C1-C4haloalkylsulfonyl, di(C1-C2)alkylaminosulfonyl, di(C1-C3)alkylaminocarbonyl, di(C1-C2)alkylaminothiocarbonyl, C1-C2alkylthioC2-C4alkylcarbonyl, phenylC1-C2alkylcarbonyl, 2-methyl-4 -chlorophenoxyacetyl, 2,4-dichlorophenoxyacetyl or thiophenylcarbonyl;


R12 is also selected from




embedded image


R13 is selected from H, C1-C4alkyl or C1-C4haloalkyl;


R14 is selected from H, C1-C4alkyl or C1C4alkoxycarbonylC1-C4alkyl;


or R13 joined together with R14 through N to form




embedded image


The most preferred compounds of general formula (I) of the invention are:


R1 is CF3;


R2 is CH3;


R3, R4 are selected from H, F or Cl;


R5, R6, R7, R8 are H;


R9 is selected from H, CN, CH3, C2H5, CH2Cl, CH2Br, CO2R11, CH2OR12 or CONR13R14;


R10 is selected from H, CH3 or C2H5;


R11 is selected from H, CH3, C2H5, CH3CH2CH2, CH3CH2CH2CH2, (CH3)2CH, (CH3)2CHCH2, (CH3)3C, CF3CH2, allyl, propargyl, CH3OCH2CH2, C2H5OCH2CH2, CH3CO2CH2CH2 or tetrahydrofuranmethyl;


R12 is selected from H, C1-C4alkylcarbonyl, C1-C4haloalkylcarbonyl, cyclopropylcarbonyl, C1-C4alkylsulfonyl, C1-C4haloalkylsulfonyl, di(C1-C2)alkylaminosulfonyl, di(C1-C3)alkylaminocarbonyl, di(C1-C2)alkylaminothiocarbonyl, C1-C2alkylthioC2-C4alkylcarbonyl, phenylC1-C2alkylcarbonyl, 2-methyl-4-chlorophenoxyacetyl, 2,4-dichlorophenoxyacetyl or thiophenylcarbonyl;


R12 is also selected from




embedded image


R13 is selected from H, CH3, C2H5, (CH3)2CH, CH3CH2CH2, CH3CH2CH2CH2, (CH3)3C, CF3CH2, CHF2CH2, CH2CH2Cl, CH2CH2CH2Cl or (CH3)CHCH2Cl;


R14 is selected from H, CH3, C2H5, (CH3)2CH, CH3CH2CH2, CH3CH2CH2CH2, (CH3)3C, or C1C4alkoxycarbonylC1-C4alkyl;


or R13 joined together with R14 through N to form




embedded image


The terms used above to definite the compounds having general formula (I) represent substitutes as follow:


Halogen or halo is fluorine, chlorine, bromine or iodine. The alkyl is to be understood as meaning straight or branched chain alkyl, such as methyl, ethyl, n-propyl, i-propyl, n-butyl, or the different butyl, pentyl or hexyl isomers. Cycloalkyl is monocyclic saturated hydrocarbonyl groups having 3 to 8 carbon atoms, such as cyclopropyl, cyclobutyl, cyclopentyl or cycloheyl etc. The haloalkyl stands for straight or branched chain alkyl, in which hydrogen atoms can be all or partly substituted with halogen, such as chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl or heptafluoroisopropyl, etc. The alkoxy refers to straight or branched chain alkyl, which is linked to the structure by oxygen atom, such as OCH3, OC2H5 or OC(CH3)3. The haloalkoxy refers to straight or branched chain alkoxy, in which hydrogen atoms may be all or partly substituted with halogen, such as chloromethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorofluoromethoxy, trifluoroethoxy, etc. The alkylthio refers to straight or branched chain alkyl, which is linked to the structure by sulfur atom. The haloalkylthio refers to straight or branched chain alkylthio, in which hydrogen atoms may be all or partly substituted with halogen, such as chloromethylthio, dichloromethylthio, trichloromethylthio, fluoromethylthio, difluoromethylthio, trifluoromethylthio, chlorofluoromethylthio, etc. The alkenyl refers to straight or branched chain alkenyl, such as ethenyl, 1-propenyl, 2-propenyl and different isomer of butenyl, pentenyl and hexenyl. Alkenyl also includes polyene, such as propa-1,2-dienyl and hexa-2,4-dienyl. The alkylsulfonyl refers to straight or branched chain alkyl, which is linked to the structure by sulfuryl, such as CH3SO2. The haloalkylsulfonyl refers to straight or branched chain alkylsulfonyl, in which hydrogen atom may be all or partly substituted with halogen. The alkoxycarbonyl refers to straight or branched chain alkoxy, which is linked to the structure by carbonyl(—CO—), such as CH3OCO or CH3CH2OCO—. The alkoxyalkyl is alkyl—O—alkyl—, such as CH3OCH2—. The alkylcarbonyloxyalkoxycarbonyl is alkyl—CO—O—alkyl—OCO—, such as CH3COOCH2OCO—, CH3COOCH2CH2OCO— or C2H5COOCH2CH2OCO—. The alkylcarbonyl refers to straight or branched chain alkyl, which is linked to the structure by carbonyl(—CO—), such as CH3CO— or CH3CH2CO—. The haloalkylcarbonyl refers to straight or branched chain alkylcarbonyl, in which hydrogen atom may be all or partyl substituted with halogen, such as CF3CO— or CF2HCO—. The cycloalkylcarbonyl refers to cycloalkyl linked to the structure by carbonyl(—CO—), such as cyclopropylcarbonyl or cyclohexylcarbonyl. The halocycloalkylcarbonyl refers to cycloalkyl linked to the structure by carbonyl(—CO—), such as 1-chlorocyclopropylcarbonyl. The alkylaminosulfonyl is alkyl—NH—SO2—, such as CH3NHSO2— or C2H5NHSO2—. The dialkylaminosulfonyl is dialkyl—NH—SO2—, such as (CH3)2NSO2— or (C2H5)2NSO2—. The alkylaminocarbonyl is alkyl—NH—CO—, such as CH3NHCO— or C2H5NHCO—. The dialkylaminocarbonyl is dialkyl—NH—CO—, such as (CH3)2NCO— or (C2H5)2NCO—. The dialkylaminothiocarbonyl is dialkyl—N—CS—, such as (CH3)2NCS— or (C2H5)2NCS—. The alkylthioalkylcarbonyl is alkyl—S—alkyl—CO, such as CH3SCH2CO or CH3SCH2CH2CO. The heteroaryl stands for five member ring or six member ring containing one or more N, O, S hetero atoms. Such as furyl, pyrazolyl, thiazolyl, pyridinyl, pyrimidinyl, pyridazinyl, triazinyl or quinoxalinyl etc. Furanmethyl, thiazolemethyl, tetrahydrofuranmethyl and pyridinemethyl can be as




embedded image


The present invention is also explained by the following compounds listed in Table 1, but without being restricted thereby. In formula (I), R1-CF3, R2=CH3, R5, R6=H, R3, R4, R7, R8, R9, R10 are listed in following Table 1.




embedded image















TABLE 1





No.
R3
R4
R7
R8
R9
R10





















1
F
Cl
H
H
CH3
CH3


2
F
Cl
H
H
C2H5
CH3


3
F
Cl
H
H
cyclo-C3H5
CH3


4
F
Cl
H
H
CO2H
CH3


5
F
Cl
H
H
CO2CH3
CH3


6
F
Cl
H
H
CO2C2H5
CH3


7
F
Cl
H
H
CO2C3H7
CH3


8
F
Cl
H
H
CO2C4H9
CH3


9
F
Cl
H
H
CO2(cyclo-C3H5)
CH3


10
F
Cl
H
H
CO2(iso-C3H7)
CH3


11
F
Cl
H
H
CO2(tert-C4H9)
CH3


12
F
Cl
H
H
CO2CH2C≡CH
CH3


13
F
Cl
H
H
CO2CH2CH═CH2
CH3


14
F
Cl
H
H
CO2CH2C(CH3)═CH2
CH3


15
F
Cl
H
H
CO2CH2CH2OC2H5
CH3


16
F
Cl
H
H
CO2CH2CH2OCH3
CH3


17
F
Cl
H
H
CO2CH2CH2OCOCH3
CH3


18
F
Cl
H
H
CO2CH2Ph
CH3


19
F
Cl
H
H
CO2CH2(4-Cl—Ph)
CH3


20
F
Cl
H
H
CO2CH2(2,6-2F—Ph)
CH3


21
F
Cl
H
H
CO2CH2(2,6-2Cl—Ph)
CH3


22
F
Cl
H
H
CONH2
CH3


23
F
Cl
H
H
CONHCH3
CH3


24
F
Cl
H
H
CONHC2H5
CH3


25
F
Cl
H
H
CONHC3H7
CH3


26
F
Cl
H
H
CONH(iso-C3H7)
CH3


27
F
Cl
H
H
CONH(cyclo-C3H5)
CH3


28
F
Cl
H
H
CONH(tert-C4H9)
CH3


29
F
Cl
H
H
CON(CH3)2
CH3


30
F
Cl
H
H
CON(C2H5)2
CH3


31
F
Cl
H
H
CON(C3H7)2
CH3


32
F
Cl
H
H
CONHCH2Ph
CH3





33
F
Cl
H
H


embedded image


CH3





34
F
Cl
H
H


embedded image


CH3





35
F
Cl
H
H


embedded image


CH3





36
F
Cl
H
H


embedded image


CH3





37
F
Cl
H
H


embedded image


CH3





38
F
Cl
H
H


embedded image


CH3





39
F
Cl
H
H


embedded image


CH3





40
F
Cl
H
H


embedded image


CH3





41
F
Cl
H
H
CN
CH3


42
F
Cl
H
H
CH2OH
CH3


43
F
Cl
H
H
CH2OCOCH3
CH3


44
F
Cl
H
H
CH2OCOC2H5
CH3


45
F
Cl
H
H
CH2OCO(cyco-C3H5)
CH3


46
F
Cl
H
H
CH2OCO(iso-C3H7)
CH3


47
F
Cl
H
H
CH2OCOC3H7
CH3


48
F
Cl
H
H
CH2OCOC4H9
CH3


49
F
Cl
H
H
CH2OCO(tert-C4H9)
CH3


50
F
Cl
H
H
CH2OCOCH2Cl
CH3


51
F
Cl
H
H
CH2OCOCH2CH2Cl
CH3


52
F
Cl
H
H
CH2OCO(CHCl)CH3
CH3


53
F
Cl
H
H
CH2OCOC(CH3)2CH2Cl
CH3


54
F
Cl
H
H
CH2OCOCH2CH2SCH3
CH3


55
F
Cl
H
H
CH2OCOCH2CH2Ph
CH3


56
F
Cl
H
H
CH2OCO(CH═CH)Ph
CH3


57
F
Cl
H
H
CH2OCOCH2CH2(4-Cl—Ph)
CH3


58
F
Cl
H
H
CH2OCO(CH═CH)(4-Cl—Ph)
CH3


59
F
Cl
H
H
CH2OCOCH2CH2(4-F—Ph)
CH3


60
F
Cl
H
H
CH2OCO(CH═CH)(4-F—Ph)
CH3


61
F
Cl
H
H
CH2OCOPh
CH3


62
F
Cl
H
H
CH2OCO(4-Cl—Ph)
CH3


63
F
Cl
H
H
CH2OCO(2,6-2Cl—Ph)
CH3


64
F
Cl
H
H
CH2OCO(2,6-2F—Ph)
CH3


65
F
Cl
H
H
CH2OCO(2,4-2Cl—Ph)
CH3


66
F
Cl
H
H
CH2OCO(2-OCH3-3,6-2Cl—Ph)
CH3


67
F
Cl
H
H
CH2OCO{2-NO2-5-[O-(2-Cl-4-CF3—Ph)]Ph}
CH3


68
F
Cl
H
H
CH2OCO{2-Cl-4-[O-(2-Cl-4-CF3—Ph)]Ph}
CH3


69
F
Cl
H
H
CH2OCO(2-Cl-4-SO2CH3—Ph)
CH3


70
F
Cl
H
H
CH2OCO(2-SO2CH3-4-CF3—Ph)
CH3


71
F
Cl
H
H
CH2OCO(2-NO2-4-SO2CH3—Ph)
CH3


72
F
Cl
H
H
CH2OCO(2-SO2CH3-4-Cl—Ph)
CH3


73
F
Cl
H
H
CH2OCO(2-thienyl)
CH3


74
F
Cl
H
H
CH2OCO(3-CH3-2-thienyl)
CH3


75
F
Cl
H
H
CH2OCO(3-Cl-2-thienyl)
CH3


76
F
Cl
H
H
CH2OCO(3-CF3-4-pyrazolyl)
CH3


77
F
Cl
H
H
CH2OCO(3-CH3-4-pyrazolyl)
CH3


78
F
Cl
H
H
CH2OCO(3-CHF2-4-pyrazolyl)
CH3


79
F
Cl
H
H
CH2OCO(3-CF3-5-Cl-4-pyrazolyl)
CH3


80
F
Cl
H
H
CH2OCO(3-CHF2-5-Cl-4-pyrazolyl)
CH3


81
F
Cl
H
H
CH2OCO(7-Cl-3-CH3-8-quinolinyl)
CH3


82
F
Cl
H
H
CH2OCO(3,7-2Cl-8-quinolinyl)
CH3


83
F
Cl
H
H
CH2OCOCH2O(2,4-2Cl—Ph)
CH3


84
F
Cl
H
H
CH2OCOCH2O(2-CH3-4-Cl—Ph)
CH3


85
F
Cl
H
H
CH2OCONHCH3
CH3


86
F
Cl
H
H
CH2OCON(CH3)2
CH3


87
F
Cl
H
H
CH2OCSN(CH3)2
CH3


88
F
Cl
H
H
CH2OSO2CH3
CH3


89
F
Cl
H
H
CH2OSO2C2H5
CH3


90
F
Cl
H
H
CH2OSO2C3H7
CH3


91
F
Cl
H
H
CH2OSO2CF3
CH3


92
F
Cl
H
H
CH2OSO2CH2Cl
CH3


93
F
Cl
H
H
CH2OSO2Ph
CH3


94
F
Cl
H
H
CH2OSO2(4-Cl—Ph)
CH3


95
F
Cl
H
H
CH2OSO2(4-CH3—Ph)
CH3


96
F
Cl
H
H
CH2OSO2N(CH3)2
CH3





97
F
Cl
H
H


embedded image


CH3





98
F
Cl
H
H
CH2Cl
CH3


99
F
Cl
H
H
CH2Br
CH3


100
F
Cl
H
H
CH2OPh
CH3


101
F
Cl
H
H
CH2O(4-Cl—Ph)
CH3


102
F
Cl
H
H
CH2O(4-F—Ph)
CH3


103
F
Cl
H
H
CH2O(4-CH3—Ph)
CH3


104
F
Cl
H
H
CH2O(2-CH3-4-Cl—Ph)
CH3


105
F
Cl
H
H
CH2O(4-CF3—Ph)
CH3


106
F
Cl
H
H
CH2O(4-CF3-2-Cl—Ph)
CH3


107
F
Cl
H
H
CH2O(3-CF3—Ph)
CH3


108
F
Cl
H
H
CH2O(2,6-2Cl—Ph)
CH3


109
F
Cl
H
H
CH2O(2,6-2F—Ph)
CH3


110
F
Cl
H
H
CH2OCH2Ph
CH3


111
F
Cl
H
H
CH2OCH2(4-Cl—Ph)
CH3


112
F
Cl
H
H
CH2OCH2(4-F—Ph)
CH3


113
F
Cl
H
H
CH2OCH2(4-CH3—Ph)
CH3


114
F
Cl
H
H
CH2OCH2(2-Cl—Ph)
CH3


115
F
Cl
H
H
CH2OCH2(4-CF3—Ph)
CH3


116
F
Cl
H
H
CH2OCH2(3-Cl—Ph)
CH3


117
F
Cl
H
H
CH2OCH2(3-CF3—Ph)
CH3


118
F
Cl
H
H
CH2OCH2(2,6-2Cl—Ph)
CH3


119
F
Cl
H
H
CH2OCH2(2,6-2F—Ph)
CH3


120
F
Cl
H
H
CO2CH3
H


121
F
Cl
H
H
CO2C2H5
H


122
F
Cl
H
H
CO2C3H7
H


123
F
Cl
H
H
CO2C4H9
H


124
F
Cl
H
H
CO2(cyclo-C3H5)
H


125
F
Cl
H
H
CO2(iso-C3H7)
H


126
F
Cl
H
H
CO2(tert-C4H9)
H


127
F
Cl
H
H
CO2CH2CH2OC2H5
H


128
F
Cl
H
H
CO2CH2CH2OCH3
H


129
F
Cl
H
H
CO2CH2CH2OCOCH3
H


130
F
Cl
H
H
CO2CH2Ph
H


131
F
Cl
H
H
CO2CH2(4-Cl—Ph)
H


132
F
Cl
H
H
CO2CH2(2,6-2F—Ph)
H


133
F
Cl
H
H
CO2CH2(2,6-2Cl—Ph)
H


134
F
Cl
H
H
CONH2
H


135
F
Cl
H
H
CONHCH3
H


136
F
Cl
H
H
CONHC2H5
H


137
F
Cl
H
H
CONHC3H7
H


138
F
Cl
H
H
CONH(iso-C3H7)
H


139
F
Cl
H
H
CONH(cyclo-C3H5)
H


140
F
Cl
H
H
CONH(tert-C4H9)
H


141
F
Cl
H
H
CON(CH3)2
H


142
F
Cl
H
H
CON(C2H5)2
H


143
F
Cl
H
H
CON(C3H7)2
H


144
F
Cl
H
H
CONHCH2Ph
H





145
F
Cl
H
H


embedded image


H





146
F
Cl
H
H


embedded image


H





147
F
Cl
H
H


embedded image


H





148
F
Cl
H
H


embedded image


H





149
F
Cl
H
H


embedded image


H





150
F
Cl
H
H


embedded image


H





151
F
Cl
H
H


embedded image


H





152
F
Cl
H
H


embedded image


H





153
F
Cl
H
H
CN
H


154
F
Cl
H
H
CH2OH
H


155
F
Cl
H
H
CH2OCOCH3
H


156
F
Cl
H
H
CH2OCOC2H5
H


157
F
Cl
H
H
CH2OCO(cyclo-C3H5)
H


158
F
Cl
H
H
CH2OCO(iso-C3H7)
H


159
F
Cl
H
H
CH2OCOC3H7
H


160
F
Cl
H
H
CH2OCOC4H9
H


161
F
Cl
H
H
CH2OCO(tert-C4H9)
H


162
F
Cl
H
H
CH2OCOCH2Cl
H


163
F
Cl
H
H
CH2OCOCH2CH2Cl
H


164
F
Cl
H
H
CH2OCO(CHCl)CH3
H


165
F
Cl
H
H
CH2OCOC(CH3)2CH2Cl
H


166
F
Cl
H
H
CH2OCOCH2CH2SCH3
H


167
F
Cl
H
H
CH2OCOCH2CH2Ph
H


168
F
Cl
H
H
CH2OCO(CH═CH)Ph
H


169
F
Cl
H
H
CH2OCOCH2CH2(4-Cl—Ph)
H


170
F
Cl
H
H
CH2OCO(CH═CH)(4-Cl—Ph)
H


171
F
Cl
H
H
CH2OCOCH2CH2(4-F—Ph)
H


172
F
Cl
H
H
CH2OCO(CH═CH)(4-F—Ph)
H


173
F
Cl
H
H
CH2OCOPh
H


174
F
Cl
H
H
CH2OCO(4-Cl—Ph)
H


175
F
Cl
H
H
CH2OCO(2,6-2Cl—Ph)
H


176
F
Cl
H
H
CH2OCO(2,6-2F—Ph)
H


177
F
Cl
H
H
CH2OCO(2,4-2Cl—Ph)
H


178
F
Cl
H
H
CH2OCO(2-OCH3-3,6-2Cl—Ph)
H


179
F
Cl
H
H
CH2OCO[2-NO2-4-O-(2Cl-4-CF3—Ph)]
H


180
F
Cl
H
H
CH2OCO[2-Cl-4-O-(2Cl-4-CF3—Ph)]
H


181
F
Cl
H
H
CH2OCO(2-Cl-4-SO2CH3—Ph)
H


182
F
Cl
H
H
CH2OCO(2-SO2CH3-4-CF3—Ph)
H


183
F
Cl
H
H
CH2OCO(2-NO2-4-SO2CH3—Ph)
H


184
F
Cl
H
H
CH2OCO(2-SO2CH3-4-Cl—Ph)
H


185
F
Cl
H
H
CH2OCO(2-thienyl)
H


186
F
Cl
H
H
CH2OCO(3-CH3-2-thienyl)
H


187
F
Cl
H
H
CH2OCO(3-Cl-2-thienyl)
H


188
F
Cl
H
H
CH2OCO(3-CF3-4-pyrazolyl)
H


189
F
Cl
H
H
CH2OCO(3-CH3-4-pyrazolyl)
H


190
F
Cl
H
H
CH2OCO(3-CHF2-4-pyrazolyl)
H


191
F
Cl
H
H
CH2OCO(3-CF3-5-Cl-4-pyrazolyl)
H


192
F
Cl
H
H
CH2OCO(3-CHF2-5-Cl-4-pyrazolyl)
H


193
F
Cl
H
H
CH2OCO(7-Cl-3-CH3-8-quinolinyl)
H


194
F
Cl
H
H
CH2OCO(3,7-2Cl-8-quinolinyl)
H


195
F
Cl
H
H
CH2OCOCH2O(2,4-2Cl—Ph)
H


196
F
Cl
H
H
CH2OCOCH2O(2-CH3-4-Cl—Ph)
H


197
F
Cl
H
H
CH2OSO2CH3
H


198
F
Cl
H
H
CH2OSO2C2H5
H


199
F
Cl
H
H
CH2OSO2C3H7
H


200
F
Cl
H
H
CH2OSO2CF3
H


201
F
Cl
H
H
CH2OSO2CH2Cl
H


202
F
Cl
H
H
CH2OSO2Ph
H


203
F
Cl
H
H
CH2OSO(4-Cl—Ph)
H


204
F
Cl
H
H
CH2OSO2(4-CH3—Ph)
H


205
F
Cl
H
H
CH2OPh
H


206
F
Cl
H
H
CH2O(4-Cl—Ph)
H


207
F
Cl
H
H
CH2O(4-F—Ph)
H


208
F
Cl
H
H
CH2O(4-CH3—Ph)
H


209
F
Cl
H
H
CH2O(2-CH3-4-Cl—Ph)
H


210
F
Cl
H
H
CH2O(4-CF3—Ph)
H


211
F
Cl
H
H
CH2O(4-CF3-2-Cl—Ph)
H


212
F
Cl
H
H
CH2O(3-CF3—Ph)
H


213
F
Cl
H
H
CH2O(2,6-2Cl—Ph)
H


214
F
Cl
H
H
CH2O(2,6-2F—Ph)
H


215
F
Cl
H
H
CH2OCH2Ph
H


216
F
Cl
H
H
CH2OCH2(4-Cl—Ph)
H


217
F
Cl
H
H
CH2OCH2(4-F—Ph)
H


218
F
Cl
H
H
CH2OCH2(4-CH3—Ph)
H


219
F
Cl
H
H
CH2OCH2(2-Cl—Ph)
H


220
F
Cl
H
H
CH2OCH2(4-CF3—Ph)
H


221
F
Cl
H
H
CH2OCH2(3-Cl—Ph)
H


222
F
Cl
H
H
CH2OCH2(3-CF3—Ph)
H


223
F
Cl
H
H
CH2OCH2(2,6-2Cl—Ph)
H


224
F
Cl
H
H
CH2OCH2(2,6-2F—Ph)
H


225
F
Cl
CH3
CH3
CO2CH3
H


226
F
Cl
CH3
CH3
CO2C2H5
H


227
F
Cl
CH3
CH3
CO2C3H7
H


228
F
Cl
CH3
CH3
CO2C4H9
H


229
F
Cl
CH3
CH3
CO2(cyclo-C3H5)
H


230
F
Cl
CH3
CH3
CO2(iso-C3H7)
H


231
F
Cl
CH3
CH3
CO2(tert-C4H9)
H


232
F
Cl
CH3
CH3
CO2CH2CH2OC2H5
H


233
F
Cl
CH3
CH3
CO2CH2CH2OCH3
H


234
F
Cl
CH3
CH3
CO2CH2CH2OCOCH3
H


235
F
Cl
CH3
CH3
CO2CH2Ph
H


236
F
Cl
CH3
CH3
CO2CH2(4-Cl—Ph)
H


237
F
Cl
CH3
CH3
CO2CH2(2,6-2F—Ph)
H


238
F
Cl
CH3
CH3
CO2CH2(2,6-2Cl—Ph)
H


239
F
Cl
CH3
CH3
CONH2
H


240
F
Cl
CH3
CH3
CONHCH3
H


241
F
Cl
CH3
CH3
CONHC2H5
H


242
F
Cl
CH3
CH3
CONHC3H7
H


243
F
Cl
CH3
CH3
CONH(iso-C3H7)
H


244
F
Cl
CH3
CH3
CONH(cyclo-C3H5)
H


245
F
Cl
CH3
CH3
CONH(tert-C4H9)
H


246
F
Cl
CH3
CH3
CON(CH3)2
H


247
F
Cl
CH3
CH3
CON(C2H5)2
H


248
F
Cl
CH3
CH3
CON(C3H7)2
H


249
F
Cl
CH3
CH3
CONHCH2Ph
H





250
F
Cl
CH3
CH3


embedded image


H





251
F
Cl
CH3
CH3


embedded image


H





252
F
Cl
CH3
CH3


embedded image


H





253
F
Cl
CH3
CH3


embedded image


H





254
F
Cl
CH3
CH3


embedded image


H





255
F
Cl
CH3
CH3


embedded image


H





256
F
Cl
CH3
CH3


embedded image


H





257
F
Cl
CH3
CH3


embedded image


H





258
F
Cl
H
CH2OH
CH3
CH3


259
F
Cl
H
CH2OCOCH3
CH3
CH3


260
F
Cl
H
CH2OCOC2H5
CH3
CH3


261
F
Cl
H
CH2OCO(cyclo-C3H5)
CH3
CH3


262
F
Cl
H
CH2OCO(iso-C3H7)
CH3
CH3


263
F
Cl
H
CH2OCOC3H7
CH3
CH3


264
F
Cl
H
CH2OCOC4H9
CH3
CH3


265
F
Cl
H
CH2OCO(tert-C4H9)
CH3
CH3


266
F
Cl
H
CH2OCOCH2Cl
CH3
CH3


267
F
Cl
H
CH2OCOCH2CH2Cl
CH3
CH3


268
F
Cl
H
CH2OCO(CHCl)CH3
CH3
CH3


269
F
Cl
H
CH2OCOC(CH3)2CH2Cl
CH3
CH3


270
F
Cl
H
CH2OCO(2-OCH3-3,6-2Cl—Ph)
CH3
CH3


271
F
Cl
H
CH2OCOCH2O(2,4-2Cl—Ph)
CH3
CH3


272
F
Cl
H
CH2OCOCH2O(2-CH3-4-Cl—Ph)
CH3
CH3


273
F
Cl
H
CH2OSO2CH3
CH3
CH3


274
F
Cl
H
CH2OSO2C2H5
CH3
CH3


275
F
Cl
H
CH2OSO2C3H7
CH3
CH3


276
F
Cl
H
CH2OSO2CF3
CH3
CH3


276
F
Cl
H
CH2OSO2CH2Cl
CH3
CH3


277
F
Cl
H
CH2OSO2(4-Cl—Ph)
CH3
CH3


278
F
Cl
H
CH2OSO2(4-CH3—Ph)
CH3
CH3


279
H
Cl
H
H
CH3
CH3


280
H
Cl
H
H
C2H5
CH3


281
H
Cl
H
H
cyclo-C3H5
CH3


282
H
Cl
H
H
CO2H
CH3


283
H
Cl
H
H
CO2CH3
CH3


284
H
Cl
H
H
CO2C2H5
CH3


285
H
Cl
H
H
CO2C3H7
CH3


286
H
Cl
H
H
CO2C4H9
CH3


287
H
Cl
H
H
CO2(cyclo-C3H5)
CH3


288
H
Cl
H
H
CO2(iso-C3H7)
CH3


289
H
Cl
H
H
CO2(tert-C4H9)
CH3


290
H
Cl
H
H
CO2CH2C≡CH
CH3


291
H
Cl
H
H
CO2CH2CH═CH2
CH3


292
H
Cl
H
H
CO2CH2C(CH3)═CH2
CH3


293
H
Cl
H
H
CO2CH2CH2OC2H5
CH3


294
H
Cl
H
H
CO2CH2CH2OCH3
CH3


295
H
Cl
H
H
CO2CH2CH2OCOCH3
CH3


296
H
Cl
H
H
CO2CH2Ph
CH3


297
H
Cl
H
H
CO2CH2(4-Cl—Ph)
CH3


298
H
Cl
H
H
CO2CH2(2,6-2F—Ph)
CH3


299
H
Cl
H
H
CO2CH2(2,6-2Cl—Ph)
CH3


300
H
Cl
H
H
CONH2
CH3


301
H
Cl
H
H
CONHCH3
CH3


302
H
Cl
H
H
CONHC2H5
CH3


303
H
Cl
H
H
CONHC3H7
CH3


304
H
Cl
H
H
CONH(iso-C3H7)
CH3


305
H
Cl
H
H
CONH(cyclo-C3H5)
CH3


306
H
Cl
H
H
CONH(tert-C4H9)
CH3


307
H
Cl
H
H
CON(CH3)2
CH3


308
H
Cl
H
H
CON(C2H5)2
CH3


309
H
Cl
H
H
CON(C3H7)2
CH3


310
H
Cl
H
H
CONHCH2Ph
CH3





311
H
Cl
H
H


embedded image


CH3





312
H
Cl
H
H


embedded image


CH3





313
H
Cl
H
H


embedded image


CH3





314
H
Cl
H
H


embedded image


CH3





315
H
Cl
H
H


embedded image


CH3





316
H
Cl
H
H


embedded image


CH3





317
H
Cl
H
H


embedded image


CH3





318
H
Cl
H
H


embedded image


CH3








319
H
Cl
H
H
CN
CH3


320
H
Cl
H
H
CH2OH
CH3


321
H
Cl
H
H
CH2OCOCH3
CH3


322
H
Cl
H
H
CH2OCOC2H5
CH3


323
H
Cl
H
H
CH2OCO(cyclo-C3H5)
CH3


324
H
Cl
H
H
CH2OCO(iso-C3H7)
CH3


325
H
Cl
H
H
CH2OCOC3H7
CH3


326
H
Cl
H
H
CH2OCOC4H9
CH3


327
H
Cl
H
H
CH2OCO(tert-C4H9)
CH3


328
H
Cl
H
H
CH2OCOCH2Cl
CH3


329
H
Cl
H
H
CH2OCOCH2CH2Cl
CH3


330
H
Cl
H
H
CH2OCO(CHCl)CH3
CH3


331
H
Cl
H
H
CH2OCOC(CH3)2CH2Cl
CH3


332
H
Cl
H
H
CH2OCOCH2CH2SCH3
CH3


333
H
Cl
H
H
CH2OCOCH2CH2Ph
CH3


334
H
Cl
H
H
CH2OCO(CH═CH)Ph
CH3


335
H
Cl
H
H
CH2OCOCH2CH2(4-Cl—Ph)
CH3


336
H
Cl
H
H
CH2OCO(CH═CH)(4-Cl—Ph)
CH3


337
H
Cl
H
H
CH2OCOCH2CH2(4-F—Ph)
CH3


338
H
Cl
H
H
CH2OCO(CH═CH)(4-F—Ph)
CH3


339
H
Cl
H
H
CH2OCOPh
CH3


340
H
Cl
H
H
CH2OCO(4-Cl—Ph)
CH3


341
H
Cl
H
H
CH2OCO(2,6-2Cl—Ph)
CH3


342
H
Cl
H
H
CH2OCO(2,6-2F—Ph)
CH3


343
H
Cl
H
H
CH2OCO(2,4-2Cl—Ph)
CH3


344
H
Cl
H
H
CH2OCO(2-OCH3-3,6-2Cl—Ph)
CH3


345
H
Cl
H
H
CH2OCO{2-NO2-5-[O-(2-Cl-4-CF3—Ph)]Ph}
CH3


346
H
Cl
H
H
CH2OCO{2-Cl-4-[O-(2-Cl-4-CF3—Ph)]Ph}
CH3


347
H
Cl
H
H
CH2OCO(2-Cl-4-SO2CH3—Ph)
CH3


348
H
Cl
H
H
CH2OCO(2-SO2CH3-4-CF3—Ph)
CH3


349
H
Cl
H
H
CH2OCO(2-NO2-4-SO2CH3—Ph)
CH3


350
H
Cl
H
H
CH2OCO(2-SO2CH3-4-Cl—Ph)
CH3


351
H
Cl
H
H
CH2OCO(2-thienyl)
CH3


352
H
Cl
H
H
CH2OCO(3-CH3-2-thienyl)
CH3


353
H
Cl
H
H
CH2OCO(3-Cl-2-thienyl)
CH3


354
H
Cl
H
H
CH2OCO(3-CF3-4-pyrazolyl)
CH3


355
H
Cl
H
H
CH2OCO(3-CH3-4-pyrazolyl)
CH3


356
H
Cl
H
H
CH2OCO(3-CHF2-4-pyrazolyl)
CH3


357
H
Cl
H
H
CH2OCO(3-CF3-5-Cl-4-pyrazolyl)
CH3


358
H
Cl
H
H
CH2OCO(3-CHF2-5-Cl-4-pyrazolyl)
CH3


359
H
Cl
H
H
CH2OCO(7-Cl-3-CH3-8-quinolinyl)
CH3


360
H
Cl
H
H
CH2OCO(3,7-2Cl-8-quinolinyl)
CH3


361
H
Cl
H
H
CH2OCOCH2(2,4-2Cl—Ph)
CH3


362
H
Cl
H
H
CH2OCOCH2O(2-CH3-4-Cl—Ph)
CH3


363
H
Cl
H
H
CH2OCONHCH3
CH3


364
H
Cl
H
H
CH2OCON(CH3)2
CH3


365
H
Cl
H
H
CH2OCSN(CH3)2
CH3


366
H
Cl
H
H
CH2OSO2CH3
CH3


367
H
Cl
H
H
CH2OSO2C2H5
CH3


368
H
Cl
H
H
CH2OSO2C3H7
CH3


369
H
Cl
H
H
CH2OSO2CF3
CH3


370
H
Cl
H
H
CH2OSO2CH2Cl
CH3


371
H
Cl
H
H
CH2OSO2Ph
CH3


372
H
Cl
H
H
CH2OSO2(4-Cl—Ph)
CH3


373
H
Cl
H
H
CH2OSO2(4-CH3—Ph)
CH3


374
H
Cl
H
H
CH2OSO2N(CH3)2
CH3


375
H
Cl
H
H
CH2Cl
CH3


376
H
Cl
H
H
CH2OPh
CH3


377
H
Cl
H
H
CH2O(4-Cl—Ph)
CH3


378
H
Cl
H
H
CH2O(4-F—Ph)
CH3


379
H
Cl
H
H
CH2O(4-CH3—Ph)
CH3


380
H
Cl
H
H
CH2O(2-CH3-4-Cl—Ph)
CH3


381
H
Cl
H
H
CH2O(4-CF3—Ph)
CH3


382
H
Cl
H
H
CH2O(4-CF3-2-Cl—Ph)
CH3


383
H
Cl
H
H
CH2O(3-CF3—Ph)
CH3


384
H
Cl
H
H
CH2O(2,6-2Cl—Ph)
CH3


385
H
Cl
H
H
CH2O(2,6-2F—Ph)
CH3


386
H
Cl
H
H
CH2OCH2Ph
CH3


387
H
Cl
H
H
CH2OCH2(4-Cl—Ph)
CH3


388
H
Cl
H
H
CH2OCH2(4-F—Ph)
CH3


389
H
Cl
H
H
CH2OCH2(4-CH3—Ph)
CH3


390
H
Cl
H
H
CH2OCH2(2-Cl—Ph)
CH3


391
H
Cl
H
H
CH2OCH2(4-CF3—Ph)
CH3


392
H
Cl
H
H
CH2OCH2(3-Cl—Ph)
CH3


393
H
Cl
H
H
CH2OCH2(3-CF3—Ph)
CH3


394
H
Cl
H
H
CH2OCH2(2,6-2Cl—Ph)
CH3


395
H
Cl
H
H
CH2OCH2(2,6-2F—Ph)
CH3


396
F
Cl
H
H
CO2CH2CF3
CH3


397
F
Cl
H
H
CO2CH2CH(CH3)2
CH3





398
F
Cl
H
H


embedded image


CH3





399
H
Cl
H
H
CO2CH2CF3
CH3


400
H
Cl
H
H
CO2CH2CH(CH3)2
CH3


401
H
Cl
H
H


embedded image


CH3









The compounds having general formula (I) in present invention can be prepared from amino-compounds III according to the literature method, such as U.S. Pat. No. 5,336,663, U.S. Pat. No. 6,992,044, WO2001083459, etc.




embedded image


The carboxylic acids(I-2,I-2′) can be prepared from the compounds I-1 or I-1′ according to the literature method when R8 or R9 is CO2C2H5, followed by the further reaction to form carboxylate compounds I-3 or I-3′ and amides according to the literature method, the references such as US20060223848, WO2012130798, WO2014048827, WO2014048940, etc.




embedded image


embedded image


The alcohols compounds I-6 or I-6′ can be prepared by reaction of the compounds I-5 or I-5′ with acetyl chloride in methanol referring to synlett, 2005, 10, 1527-1530. And then the compounds I-7 or I-7′ was obtained by reaction of alcohols compounds I-6 or I-6′ with R12-X which is acyl halide, benzyl halide, halogenobenzene or halogenoheteroaryl under basic conditions.




embedded image


embedded image


The reaction was carried out in proper solvent and the proper solvent mentioned may be selected from benzene, toluene, xylene, acetone, tetrahydrofuran, acetonitrile, N,N-dimethylformamide, N-methylpyrrolidane, dichloromethane, chloroform, dichloroethane, ethyl acetate, etc. The reaction can be carried out under base or no base conditions, and the reaction can be accelerated in the condition of base. The proper base mentioned may be selected from alkali metal hydride, such as NaH, LiH, NaNH2, and so on; or alkali metal hydroxide, such as KOH, NaOH, and so on; or alkali carbonate, such as K2CO3, Na2CO3, and so on; or organo-alkali, such as pyridine, 4-dimethylaminopyridine, triethylamine, N-methylpyrrolidine, N, N-diisopropylethylamine, and so on. The proper temperature mentioned is from −10° C. to boiling point of solvent, normally the temperature is at 0 to 100° C. The reaction time is in the range of 30 minutes to 20 hours, generally being 1-10 hours.


R12-X is commercially available. The X is leaving group selected from Cl, Br or I.


The amino-compounds III can be prepared from nitro compounds IV according to conventional methods by reductants, such as Fe, Zn, Pd/C, SnCl2, and so on, referring to EP2044006, US20070155738, European Journal of Medicinal Chemistry, 2013, 65, 32-40, Synlett, 2010, (20), 3019-3022, Heterocycles, 2008, 75(1), 57-64, etc. The nitro compounds IV can be prepared from aldehydes VIII by three steps reactions according to the literature method, such as J. Agric. Food Chem. 2005, 53, 8639-8643 or WO2006090234.




embedded image


Each group of formulas is as defined above except special explanation.


The present invention compounds can effectively control weeds, such as Echinochloa crusgalli, Setaria viridis, Cyperus difformis, Juncellus serotinus, Digitaria sangunalis, Arthraxon hispidus, Abutilon theophrasti, Zinnia elegans, Amaranthus retrofluxes, Portulaca oleracea, Xanthium sibiricum, Solanum nigrum, Cassia tora, Hibiscus trionum, Glycine soja, an so on. They can effectively control weeds even at lower doses. The present invention compounds are also safe to wheats, corns and rices, and can used as herbicides in agriculture fields. Therefore, the present invention also includes the use of the compounds having general formula (I) as herbicides to control weeds.


A further object of the present invention relates to herbicidal compositions containing compounds having general formula (I) as active ingredient, the active component of the compositions in the weight ratio of 0.1-99%. Therefore, the present invention also includes the use of the compositions as herbicides to control weeds.


Compositions can be used in the form of dry powders, wettable powders, emulsifiable concentrates, microemulsions, pastes, granulates, solutions, suspensions, etc.: the selection of the type of composition depends on the specific use.


The compositions are prepared in the known way, for example by diluting or dissolving the active substance with a solvent medium and/or a solid diluent, optionally in the presence of surface-active agents.


Solid diluents or carriers which can be used include, for example: silica, kaolin, bentonite, talc, diatomite, dolomite, calcium carbonate, magnesia, chalk, clays, synthetic silicates, attapulgite, seppiolite and so on.


Liquid diluents which can be used include, for example, in addition to water, aromatic organic solvents (xylols or mixtures of alkylbenzols, chlorobenzene, etc.), paraffins (petroleum fractions), alcohols (methanol, propanol, butanol, octanol, glycerin), esters (ethyl acetate, isobutyl acetate, etc.), ketones (cyclohexanone, acetone, acetophenone, isophorone, ethylamylketone, etc.), amides (N,N-dimethylformamide, N-methylpyrrolidone, etc.).


Surface-active agents which can be used include salts of sodium, calcium, triethylamine or triethanolamine of alkylsulfonates, alkylarylsulfonates, polyethoxylated alkylphenols, polyethoxylated esters of sorbitol, ligninsulfonates, etc.


The compositions can also contain special additives for particular purposes, for example adhesion agents such as Arabic gum, polyvinyl alcohol, polyvinyl-pyrrolidone, etc.


The concentration of active ingredient in the above compositions can vary within a wide range depending on the active compound, the applications for which they are destined, the environmental conditions and the type of adopted formulation. In general the concentration of active ingredient ranges from 0.5 to 90%, preferably from 5 to 60%.


If required, other active ingredients being compatible with the compounds having general formula (I) can be added to the compositions, such as, other acaricides/insecticides, fungicides, plant growth regulators, antibiotics, herbicides, fertilizers.


The preparation methods of several common formulations examples in the present invention are as follows:


The preparation of suspension concentrate: in commonly used for producing the suspension concentrate, the active component in formula is 5% -35%. With water as the medium, the compound in the invention, dispersing agent, suspending agent and antifreeze are added to sanding machine for grinding to make suspension concentrate.


The preparation of water emulsion: the compound in the invention, solvent and emulsifier are mixed together, to make a homogeneous oil phase. The water is mixed with antifreeze to make a homogeneous water phase. In the high-speed stirring, the aqueous phase is added to the oil phase or oil phase is added to the aqueous phase, forming the water emulsion with good dispersity. The active component of water emulsions is generally 5% -15% in this invention. For the production of concentrated emulsions, the compounds of this invention are dissolved in one or more of the mixed solvent, and then emulsifier was added to enhance dispersion effects in the water.


The preparation of wettable powder: according to formulation requirements, the compound in the invention, surfactants and solid diluents are mixed well, after smashing through ultrafine pulverizer, that is the wettable powder products (for example, 10%-60%). For the preparation of the spraying wettable powder, the compounds of this invention can be formed the mixture with solid powder, such as clay, inorganic silicates, carbonates, as well as wetting agents, adhesives and/or dispersant agent.


The preparation of water dispersible granules: the compound in the invention and powdered solid diluents, wetting agents and adhesives are mixed to smash, kneading together with water, added to the granulation certain mesh machine for granulation, then by drying and sieving (at the scope screen). Also, the compound in the invention, dispersants, disintegrates, wetting agents and solid diluent are added to sanding machine, grinding in water to produce suspension and then spray-drying granulation, usually the content of the prepared granular products is 20% -30%.


Furthermore, the compounds having general formula (I) are also suitable for the desiccation and/or defoliation of plants.







DESCRIPTION OF THE INVENTION IN DETAIL

The following examples are illustrative of the present invention, but without being restricted thereby. (All the starting materials are commercially available except special explanation).


PREPARATION EXAMPLE
Example 1 The Preparation of Compound 6



embedded image




    • 1) The preparation of 2-chloro-4-fluoro-5-nitrobenzaldehyde oxime





The hydroxylamine hydrochloride aqueous solution 17.4 g (0.25 mol) was added dropwise to a solution of 2-chloro-4-fluoro-5-nitrobenzaldehyele 42 g (0.206 mol) with ethanol (200 ml) at 0° C. The mixture was stirred 2 h at room temperature, the reaction was completed by TLC monitoring. The solution was poured into water, and the precipitate solid was filtered off with suction, to give 38.3 g white solid, m.p. 103° C.

    • 2) The preparation of Ethyl


      3-(2-chloro-4-fluoro-5-nitrophenyl)-5-methyl-4,5-dihydroisoxazole-5-carboxylate


2-chloro-4-fluroro-5-nitrobenzaldoxime 43.7 g (0.2 mol) was dissolved in 150 ml N,N-dimethylformamide, followed NCS 32 g (0.24 mol) was added in portion at 30° C. The mixture formed light yellow solution, and maintained for 1 h at 35° C., then cooled to room temperature, 300 ml dichloromethane was added, and washed twice with 1 N hydrochloric acid, then washed twice with brine. The organic layer was dried over MgSO4, filtered, cooled to 0-5° C., followed the mixture of ethyl methacrylate 34.2 g(0.3 mol) and triethylamine 31 g (0.3 mol) were added dropwise to filtrate, and stirred at this temperature for 1 h. 1 N hydrochloric acid and brine were added to wash the reaction solution, the organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated in vacuo, then the residue was purified through silica column (ethyl acetate/petroleum ether (boiling point range 60-90° C.)=1:3, as an eluent) to give 57 g compound as yellow solid, m.p. 73.5° C. 1H-NMR spectrum(300 MHz, internal standard: TMS, solvent CDCl3) δ(ppm): 1.28(t, 3 H), 1.71(s, 3 H), 3.32(d, 1 H), 3.92(d, 1 H), 4.27(q, 2 H), 7.42(d, 1 H), 8.45(d, 1 H).

    • 3) The preparation of


      3-(5-amino-2-chloro-4-fluorophenyl)-5-methyl-4,5-dihydroisoxazole-5-carboxylate


Ethyl 3-(2-chloro-4-fluoro-5-nitrophenyl)-5-methyl-4,5-dihydroisoxazole-5-carboxylate 57 g (0.18 mol) was dissolved in ethyl acetate(300 ml), then stannous chloride dihydrate 163 g (0.72 mol) was added in portion when heated. The mixture was stirred at refluxing for 8 h. After the reaction was over by TLC monitoring, the reaction mixture was poured into ice water, the mixture was adjusted to pH8 using sodium hydroxide and extracted with ethyl acetate, washed with saturated brine the extract was dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give 31 g oil for next step without further purification.

    • 4) The preparation of 2-(dimethylamino)-4-(trifluoromethyl)-6H-1,3-oxazin-6-one


Phosgene iminium chloride 25 g(0.15 mol) was added to 100 ml trichloromethane and heated to 60° C., the mixture of ethyl 3-amino-4,4,4-trifluorocrotonate 25 g(0.14 mol) and 15 ml trichloromethane was added, the mixture was stirred at refuxing for 4 h. After the reaction was over by TLC monitoring, the mixture was cooled to room temperature and added saturated sodium bicarbonate solution. The organic layer was washed with saturated brine and dried over anhydrous magnesium sulfate and concentrated under reduced pressure, to give 30.8 g yellow solid, m.p. 81.7° C.

    • 5) The preparation of ethyl


      3-(2-chloro-5-(2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl)-4-fluorophenyl)-5-methyl-4,5-dihydroisoxazole-5-carboxylate


Ethyl 3-(5-amino-2-chloro-4-fluorophenyl)-5-methyl-4,5-dihydroisoxazole-5-carboxylate 13.2 g(0.046 mol) and 2-(dimethylamino)-4-(trifluoromethyl)-6H-1,3-oxazin-6-one 9.8 g(0.047 mol) were added to flask with acetic acid (100 mL) in sequence, the reaction mixture was then heated to reflux turning dark, and maintained for 6 h. The mixture was concentrated under reduced pressure, followed by adjusting to a pH of 7 using sodium bicarbonate solution, extracted with ethyl acetate, and dried over anhydrous magnesium sulfate and concentrated under reduced pressure, recrystallizated with ethanol, to give 14.5 g white solid, m.p. 105.7° C.



1H-NMR spectrum(300 MHz, internal standard: TMS, solvent CDCl3) δ(ppm): 1.33(t, 3 H), 1.71(s, 3 H), 3.34(d, 1 H), 3.89(d, 1 H), 4.27(m, 2 H), 6.21(s, 1 H), 7.36(d, 1 H), 7.71(d, 1 H).

    • 6) The preparation of compound 6


Ethyl

3-(2-chloro-5-(2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl)-4-fluorophenyl)-5-methyl-4,5-dihydroisoxazole-5-carboxylate 14 g (0.031 mol) and potassium carbonate 12.9 g (0.094 mol) were added to flask with N,N-dimethylformamide (150 mL) in sequence. The reaction mixture was cooled to 0° C., followed by addition of iodine methane 8.9 g (0.062 mol) dropwise, then raised temperature to room temperature, and maintained for 6 h. After the reaction was over by TLC monitoring, the mixture was poured into water and extracted with ethyl acetate, washed with saturated brine and dried over anhydrous magnesium sulfate and concentrated under reduced pressure, then the residue was purified through silica column (ethyl acetate/petroleum ether (boiling point range 60-90° C.)=⅕, as an eluent) to give 13.2 g oil.



1H-NMR spectrum(300 MHz, internal standard: TMS, solvent CDCl3) δ(ppm): 1.35(t, 3 H), 1.68(s, 3 H), 3.38(d, 1 H), 3.60(s, 3 H), 3.90(d, 1 H), 4.30(m, 2 H), 6.25(s, 1 H), 7.38(d, 1 H), 7.79(d, 1 H).


Example 2 The Preparation of Compound 5

Compound 5 was prepared according to the preparation process of compound 6 in example 1 to obtain oil, only replacing ethyl methacrylate with methyl methacrylate in step 2.



1H-NMR spectrum(300 MHz, internal standard: TMS, solvent CDCl3) δ(ppm): 1.70(s, 3 H), 3.38(d, 1 H), 3.56(s, 3 H), 3.99(d, 1 H), 4.32(s, 3 H), 6.36(s, 1 H), 7.36(d, 1 H), 7.69(d, 1 H).


Example 3 The Preparation of Compound 4

The compound 6 was added to flask with ethanol (20 mL), followed by addition of sodium hydroxide aqueous solution 2.76 g (0.069 mol). The mixture was stirred at room temperature for 4 h. After the reaction was over by TLC monitoring, the mixture was poured into water and acidified to pH 3 with 1 N HCl. The precipitate was collected by filtration, dried in vacuum to afford 9.2 g white solid, m.p. 212.3° C.


Example 4 The Preparation of Compound 10

Compound 4 0.42 g (0.89 mmol), 2-bromopropane 0.11 g(0.89 mmol), potassium carbonate 0.2 g(1.45 mmol) were added to flask with acetonitrile(20 mL) in sequence, the reaction mixture was then heated to reflux for 2 h. After the reaction was over by Thin-Layer Chromatography monitoring, the mixture was filtered and concentrated under reduced pressure, then the residue was purified through silica column (ethyl acetate/petroleum ether (boiling point range 60-90° C.)=¼, as an eluent) to give 0.2 g oil.



1H-NMR spectrum(300 MHz, internal standard: TMS, solvent CDCl3) δ(ppm): 1.25(m, 6 H), 1.69(s, 3 H), 3.37(m, 1 H), 3.56(s, 3 H), 3.93(m, 1 H), 5.07(m, 1 H), 6.36(s, 1 H), 7.37(d, 1 H), 7.68(d, 1 H).


Example 5 The Preparation of Compound 17

Compound 17 was prepared according to the preparation process of compound 6 in example 1 to obtain oil, only replacing ethyl methacrylate with hydroxyethyl methacrylate.



1H-NMR spectrum(300 MHz, internal standard: TMS, solvent CDCl3) δ(ppm): 1.72(s, 3 H), 2.61(s, 3 H), 3.38(m, 1 H), 3.56(s, 3 H), 3.95(m, 1 H), 4.05(t, 2 H), 4.30(t, 2 H), 6.37(s, 1 H), 7.34(d, 1 H), 7.69(d, 1 H).


Example 6 The Preparation of Compound 22

The compound 6 0.46 g(1 mmol) was dissolved in 15 ml tetrahydrofuran, followed by addition of ammonium hydroxide (25%) 0.42 g (3 mmol), The mixture was stirred at room temperature for 6 h. After the reaction was over by TLC monitoring, the mixture was poured into water, a precipitate was collected by filtration, dried in vacuum to afford compound 22 0.18 g as a white solid, m.p. 165.4° C.



1H-NMR spectrum(300 MHz, internal standard: TMS, solvent CDCl3) δ(ppm): 1.59(s, 3 H), 3.24(s, 3 H), 3.30(d, 1 H), 3.77(d, 1 H), 6.42(s, 1 H), 7.29(s, 1 H), 7.38(d, 1 H), 8.47(d, 1 H),


Example 7 The Preparation of Compound 23

Compound 23 was prepared according to the preparation process of compound 22 in example 6 to obtain white solid, m.p. 225.5° C. only replacing ammonium hydroxide with ethylamine (25%).



1H-NMR spectrum(300 MHz, internal standard: TMS, solvent CDCl3) δ(ppm): 1.61(s, 3 H), 3.24(d, 3 H), 3.30(d, 1 H), 3.56(s, 3 H), 3.87(d, 1 H), 6.32(s, 1 H), 7.28(s, 1 H), 7.69(d, 1 H).


Example 8 The Preparation of Compound 26



embedded image




    • 1) The preparation of


      3-(2-chloro-4-fluoro-5-(3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl)phenyl)-5-methyl-4,5-dihydroisoxazole-5-carbonyl chloride





The compound 4 9 g (0.02 mol) was dissolved in 20 ml dichloromethane, followed oxalyl chloride 7.62 g (0.06 mol) was added dropwise. The mixture was stirred at room temperature for 4 h. After the reaction was over by TLC monitoring, the mixture was concentrated under reduced pressure to give 9 g oil, for next step without further purification.


The carbonyl chloride afforded by step 1 0.45 g (0.001 mol) was dissolved in 10 ml dichloromethane, followed the mixture of isopropylamine 0.1 g (0.0015 mol) and triethylamine 0.21 g (0.002 mol) were added carefully. The mixture was stirred at room temperature for 1 h. The reaction was over by TLC monitoring, the mixture was concentrated under reduced pressure, purified through silica column (ethyl acetate/petroleum ether (boiling point range 60-90° C.)=⅛, as an eluent) to give 0.2 g yellow solid, m.p. 201.6° C.



1H-NMR spectrum(300 MHz, internal standard: TMS, solvent CDCl3) δ(ppm): 1.18(m, 6 H), 1.69(s, 3 H), 3.33(d, 1 H), 3.56(s, 3 H), 3.81(d, 1 H), 4.05(m, 1 H), 5.14(m, 1 H), 6.73(s, 1 H), 7.14(d, 1 H), 8.38(d, 1 H).


Example 9 The Preparation of Compound 35

Compound 35 was prepared according to the preparation process of compound 26 in example 8 to obtain yellow oil, only replacing isopropylamine with methyl isonipecotate.



1H-NMR spectrum(300 MHz, internal standard: TMS, solvent CDCl3) δ(ppm): 1.59(m, 4 H), 1.76(s, 3 H), 2.05(m, 1 H), 3.39(d, 1 H), 3.48(m, 4 H), 3.60(s, 3 H), 3.96(d, 1 H), 6.25(s, 1 H), 7.29(d, 1 H), 8.68(d, 1 H).


Example 10 The Preparation of Compound 42 and 43



embedded image




    • 1) (E)-2-chloro-4-fluoro-5-nitrobenzaldehyde oxime was prepared according to step 1 of example 1.

    • 2) preparation of (3-(2-chloro-4-fluroro-5-nitrophenyl)-5-methyl-4,5-dihydro-isoxazole-5-yl) methanol





2-chloro-4-fluroro-5-nitrobenzaldoxime 56.8 g (0.26 mol) was dissolved in 150 ml N,N-dimethylformamide, followed by addition of NCS 41.4 g (0.31 mol) in portion at 30° C. The mixture formed light yellow solution, and maintained 1 h at 35° C., then cooled to room temperature, followed by addition of 300 ml dichloromethane, and washed twice with 1 N hydrochloric acid, then washed twice with brine. The organic layer was dried over MgSO4, filtered, cooled to 0-5° C., followed the mixture of methyl-2-propen-1-ol 24.5 g (0.34 mol) and triethylamine 34.4 g (0.34 mol) were added dropwise to filtrate, and stirred at this temperature for 1 h. 1 N hydrochloric acid and brine were added to wash the reaction solution, the organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated in vacuo, then the residue was purified through silica column (ethyl acetate/petroleum ether (boiling point range 60-90° C.)=1:3, as an eluent) to give 34 g compound as yellow solid, m.p. 117.1° C.



1H-NMR spectrum(300 MHz, internal standard: TMS, solvent CDCl3) δ(ppm): 1.47(s, 3 H), 3.18(d, 1 H), 3.62(s, 2 H), 3.79(d, 1 H), 7.43(d, 1 H), 8.42(d, 1 H).

    • 3) preparation of


      (3-(2-chloro-4-fluroro-5-aminophenyl)-5-methyl-4,5-dihydro-isoxazole-5-yl) methanol


(3-(2-chloro-4-fluroro-5-nitrophenyl)-5-methyl-4,5-dihydro-isoxazole-5-yl) methanol 40 g(0.139 mol) was dissolved in 200 ml ethyl acetate, followed by addition of stannous chloride dihydrate 109.5 g (0.49 mol) in portion under heating. The mixture was stirred at reflux for 8 h. After the reaction was over by TLC monitoring, the reaction mixture was poured into ice water, the mixture was adjusted to a pH of 8 using sodium hydroxide and extracted with ethyl acetate, washed with saturated brine, the extract was dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give 27 g oil for next step without further purification.

    • 4) preparation of


      (3-(2-chloro-5-(2,6-dioxo-4-trifluoromethyl-3,6-dihydropyrimidine-1-(2H)-yl)-4-flourophenyl)-5-methyl-4,5-dihydro-isoxazole-5-yl) methyl acetate


(3-(2-chloro-4-fluroro-5-aminophenyl)-5-methyl-4,5-dihydro-isoxazole-5-yl) methanol 19.5 g (0.0754 mol) and 2-(dimethylamino)-4-(trifluoromethyl)-6H-1,3-oxazin-6-one 17.3 g (0.083 mol, step 4 of example 1) were added to flask with 100 mL acetic acid in sequence, the reaction mixture- was then heated to reflux turning dark, and maintained for 6 h. The mixture was concentrated under reduced pressure, followed by adjusting to a pH of 7 using sodium bicarbonate solution, extracted with ethyl acetate, and dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give 30.5 g white solid, m.p. 80.2° C.



1H-NMR spectrum(300 MHz, internal standard: TMS, solvent CDCl3) δ(ppm): 1.39(s, 3 H), 2.01(s, 3 H), 3.27(d, 1 H), 3.48(d, 1 H), 4.13(m, 2 H), 6.21(s, 1 H), 7.61(d, 1 H), 7.78(d, 1 H), 12.78(s, 1 H).

    • 5) The preparation of compound 43


(3-(2-chloro-5-(2,6-dioxo-4-trifluoromethyl-3,6-dihydropyrimidine-1-(2H)-yl)-4-fluorophenyl)-5-methyl-4,5-dihydro-isoxazole-5-yl) methyl acetate 30.5 g(0.066 mol) and potassium carbonate 18.2 g (0.132 mol) were added to flask with N,N-dimethylformamide (150 mL) in sequence. The reaction mixture was cooled to 0° C., followed by addition of iodine methane 11.4 g(0.08 mol) dropwise, then raised temperature to room temperature, and maintained for 6 h. After the reaction was over by TLC monitoring, the mixture was poured into water and extracted with ethyl acetate, washed with saturated brine and dried over anhydrous magnesium sulfate and concentrated under reduced pressure, then the residue was purified through silica column (ethyl acetate/petroleum ether (boiling point range 60-90° C.)=⅕, as an eluent) to give 25 g oil.



1H-MMR spectrum(300 MHz, internal standard; TMS, solvent CDCl3) δ(ppm): 1.41(s, 3 H), 2.03(s, 3 H), 3.25(d, 1 H), 3.50(d, 1 H), 3.62(s, 3 H), 3.87(m, 2 H), 6.21(s, 1 H), 7.51(d, 1 H), 7.70(d, 1 H).

    • 6) The preparation of compound 42


Compound 40 25 g (0.052 mol) was added to flask with 100 ml methanol, followed by addition of acetyl chloride 0.59 g (0.0078 mol) dropwise, the reaction mixture was stirred at room temperature for 8 h. After the reaction was over by TLC monitoring, the mixture was concentrated under reduced pressure, then the residue was added dichloromethane, sodium hydrogen carbonate solution, organic phase was dried over anhydrous magnesium sulfate and concentrated under reduced pressure, then the residue was purified through silica column (ethyl acetate/petroleum ether (boiling point range 60-90° C.)=¼, as an eluent) to give 15.4 g white solid, m.p. 161° C.



1H-NMR spectrum(300 MHz, internal standard: TMS, solvent CDCl3) δ(ppm): 1.43(s, 3 H), 3.20(m, 1 H), 3.59(s, 3 H), 3.73(m, 1 H), 3.79(m, 2 H), 6.40(s, 1 H), 7.37(m, 1 H), 7.68(m, 1 H).


Example 11 The Preparation of Compound 45

Compound 42 0.4 g (0.9 mmol) and cyclopropanecarbonyl chloride 0.1 g(0.9 mmol) were added to flask with 15 ml toluen in sequence, followed by addition of triethylamine 0.14 g(1.35 mmol), then the reaction mixture stirred at room temperature for 2 h. After the reaction was over by TLC monitoring, the mixture was concentrated under reduced pressure, then the residue was purified through silica column (ethyl acetate/petroleum ether (boiling point range 60-90° C.)=¼, as an eluent) to give 0.5 g buff oil.



1H-NMR spectrum(300 MHz, internal standard: TMS, solvent CDCl3) δ(ppm): 0.87(2 H, q), 1.01(2 H, q), 1.40(s, 3 H), 1.62(1 H, m), 3.24(1 H, d), 3.48(1 H, d), 3.56(3 H, s), 4.17 (2 H, t), 6.36(1 H, s), 7.35(1 H, d), 7.67(1 H, d).


Example 12 The Preparation of Compound 99

Compound 42 2 g (4.6 mmol) and carbon tetrabromide 2.3 g(6.8 mmol) were added to flask with 30 ml dichloromethane in sequence, followed by addition of triphenylphosphine 1.8 g(6.8 mmol) at room temperature, the reaction mixture was then heated to reflux after 30 min, maintained additional 6 h, the reaction was over by TLC monitoring, the mixture was cooled to room temperature, filtrated, concentrated under reduced pressure, then the residue was purified through silica column (ethyl acetate/petroleum ether (boiling point range 60-90° C.)=⅕, as an eluent) to give 0.59 g buff oil.



1H-NMR spectrum(300 MHz, internal standard: TMS, solvent CDCl3) δ(ppm): 1.43(s, 3 H), 3.28(m, 1 H), 3.62(s, 3 H), 3.68(m, 1 H), 3.85(m, 2 H), 6.43(s, 1 H), 7.39(m, 1 H), 7.70(m, 1 H).


Example 13 The Preparation of Compound 320 and 321



embedded image


Compound 320 and 321 were prepared according to the preparation process of compound 42 and 43 in example 10, only replacing 2-chloro-4-fluoro-5-nitrobenzaldehyde with 2-chloro-5-nitrobenzaldehyde.


Compound 46, 50, 54, 55, 66, 67, 83, 88, 90, 96, 323, 324, 328, 329, 332, 333, 345 and 366 were prepared according to the preparation process of example 11.


Compound 282 was prepared according to the preparation process of compound 4 in example 3.


Compound 7, 8, 15, 16, 284, 396, 397 and 398 was prepared according to the preparation process of compound 6 in example 1.


Compound 286 and 290 was prepared according to the preparation process of compound 6 in example 4.


Physical properties and 1H NMR spectrum of some compounds of this invention refer to Table 2.










TABLE 2





No.
Physical properties and 1H NMR spectrum (300 MHz, internal standard TMS, solvent CDCl3)
















7
Oil; δppm 0.96 (3H, t), 1.71 (3H, s), 1.73 (3H, m), 3.38 (1H, d), 3.55 (3H, s), 4.02 (1H, d),



4.17 (2H, t), 6.36 (1H, s), 7.35 (1H, d), 7.68 (1H, d)


8
Oil; δppm 0.94 (3H, t), 1.38 (4H, m), 1.71 (3H, s), 3.37 (1H, d), 3.55 (3H, s), 3.99 (1H, d),



4.21 (2H, t), 6.36 (1H, s), 7.35 (1H, d), 7.68 (1H, d)


15
Oil; δppm 1.18 (3H, t), 1.72 (3H, s), 2.91 (1H, d), 3.38 (2H, m), 3.51 (3H, s), 3.67 (2H, t), 3.99 (1H,



d), 4.35 (2H, t), 6.36 (1H, s), 7.34 (1H, d), 7.67 (1H, d)


16
Oil; δppm 1.29 (3H, t), 1.71 (3H, s), 2.95 (d, 1H), 3.55 (s, 3H), 3.82 (d, 1H), 4.00 (t, 2H), 4.27 (t, 2H),



6.35 (s, 1H), 7.34 (d, 1H), 7.68 (d, 1H)


46
Oil; δppm 1.15-1.21 (6H, m), 1.51 (3H, s), 2.57-2.61 (1H, m), 3.26 (1H, d), 3.48 (1H, d), 3.66 (3H, s),



4.12-4.23 (2H, dd), 6.37 (1H, s), 7.34 (1H, d), 7.66 (1H, d)


50
Oil; δppm 1.57 (3H, s), 3.25-3.34 (2H, dd), 3.57 (3H, s), 4.11 (2H, d), 4.21-4.35 (2H, dd), 6.38 (1H, s),



7.36 (1H, d), 7.36 (1H, d)


54
Oil; δppm 1.51 (3H, s), 2.09 (3H, s), 2.60-2.83 (6H, m), 3.55 (3H, s), 4.15-4.26 (2H, dd), 6.36 (1H, s),



7.34 (1H, d), 7.65 (1H, d)


55
Oil; δppm 1.45 (3H, s), 2.68 (2H, m), 3.23 (2H, d), 3.36 (2H, d), 3.54 (3H, s), 4.12-4.18 (2H, dd),



6.34 (1H, s), 7.17-7.25 (5H, m), 7.35 (1H, d), 7.66 (1H, d)


66
Oil; δppm 1.57 (3H, s), 3.26 (1H, d), 3.56 (3H, s), 3.61 (1H, d), 3.90 (3H, s), 4.41-4.53 (2H, dd), 6.37 (1H,



s), 7.12 (1H, d), 7.34 (2H, m), 7.63 (1H, m)


67
Oil; δppm 1.53 (3H, s), 3.18-3.29 (2H, dd), 3.55 (3H, s), 4.34-4.44 (2H, dd), 6.36 (1H, s), 7.06 (1H, m),



7.15 (1H, m), 7.24 (1H, d), 7.35 (1H, d), 7.62 (2H, d), 7.80 (1H, d), 8.03 (1H, d)


83
Oil; δppm 1.49 (3H, s), 3.25-3.44 (2H, dd), 3.56 (3H, s), 4.20-4.37 (2H, dd), 4.73 (2H, d), 6.36 (1H, s),



6.78 (1H, d), 7.15 (1H, m), 7.36 (2H, t), 7.42 (1H, m)


88
Oil; δppm 1.55 (3H, s), 3.15 (3H, s), 3.26 (1H, m), 3.61 (3H, s), 3.67 (1H, m), 4.25-4.33 (2H, dd),



6.37 (1H, s), 7.35 (1H, d), 7.63 (1H, d)


90
Oil; δppm 1.06 (3H, t), 1.57 (3H, s), 1.92 (2H, m), 3.16 (2H, m), 3.25 (2H, m), 3.62 (3H, s), 4.23 (2H, s),



6.37 (1H, s), 7.36 (1H, d), 7.63 (1H, d)


96
oil; δppm 1.55 (3H, s), 3.06 (3H, s), 3.31 (3H, s), 3.44-3.56 (2H, dd), 3.61 (3H, s), 4.47-4.63 (2H, dd),



6.37 (1H, s), 7.34 (2H, s), 7.68 (1H, d).


282
Oil; δppm 1.56 (3H, s), 3.02 (1H, d), 3.23 (1H, d), 3.43 (3H, s), 6.36 (1H, s), 7.32 (2H, m), 7.47 (1H, d),



8.05 (1H, s)


284
Oil; δppm 1.14 (3H, t), 1.67 (3H, s), 3.22 (2H, d), 3.55 (2H, d), 3.66 (3H, s), 4.22 (2H, q), 6.36 (1H, s),



7.46 (1H, d), 7.63 (1H, d), 7.73 (1H, d)


286
Oil; δppm 0.94 (3H, t), 1.26 (2H, t), 1.43 (2H, t), 1.67 (3H, s), 3.38 (1H, d), 4.02 (1H, d), 4.15 (3H, s),



4.21 (2H, t), 6.36 (1H, s), 7.13 (1H, s), 7.56 (2H, m)


290
Oil; δppm 1.74 (3H, s), 3.46 (1H, d), 3.55 (3H, s), 4.00 (1H, d), 4.78 (2H, d), 6.36 (1H, s), 7.54 (2H, m),



8.02 (1H, s)


320
Oil; δppm 1.52 (3H, s), 3.03 (1H, d), 3.24 (1H, d), 3.46 (3H, s), 4.52 (1H, s), 6.36 (1H, s), 7.33 (2H, m),



7.48 (1H, d)


321
oil; δppm 1.48 (3H, s), 2.07 (3H, s), 2.85 (2H, d), 3.25 (2H, d), 3.51 (3H, s), 4.15 (2H, dd), 6.34 (1H, s),



7.19 (1H, dd), 7.55 (1H, dd)


323
Oil; δppm 0.88 (2H, m), 1.26 (2H, m), 1.51 (3H, s), 1.66 (1H, m), 3.27 (1H, d), 3.49 (1H, d), 3.57 (3H, s),



4.17 (2H, dd), 6.36 (1H, s), 7.22 (1H, m), 7.58 (2H, m)


324
Oil; δppm 1.13 (6H, m), 1.51 (3H, s), 2.60 (1H, m), 3.34 (2H, dd), 3.55 (3H, s), 4.18 (2H, m), 6.37 (1H, s),



7.20 (1H, m), 7.58 (2H, m)


328
Oil; δppm 1.54 (3H, s), 3.31 (1H, d), 3.53 (1H, d), 3.61 (3H, s), 4.10 (2H, s), 4.28 (2H, dd), 6.37 (1H, s),



7.22 (1H, d), 7.57 (2H, s)


329
Oil; δppm 1.53 (3H, s), 2.05 (2H, t), 2.62 (2H, d), 3.29 (1H, d), 3.53 (1H, d), 4.27 (2H, dd), 6.37 (1H, s),



7.21 (1H, d), 7.57 (2H, m)


332
Oil; δppm 1.51 (3H, s), 2.05 (3H, s), 2.12 (2H, d), 2.66 (2H, m), 3.25 (1H, d), 3.52 (1H, d), 3.55 (3H, s),



4.18 (2H, d), 6.34 (1H, s), 7.19 (1H, d), 7.54 (2H, m)


333
Oil; δppm 1.46 (3H, s), 2.67 (2H, t), 3.96 (2H, t), 3.23 (1H, d), 3.40 (1H, d), 3.52 (3H, s), 6.36 (1H, s),



7.19 (5H, m), 7.32 (2H, m), 7.56 (1H, s).


345
Oil; δppm 1.55 (3H, s), 3.22 (2H, dd), 3.56 (3H, s), 4.40 (2H, dd), 6.36 (1H, s), 7.15 (4H, m), 7.53 (2H, m),



7.59 (1H, m), 7.80 (1H, s), 8.02 (1H, d)


366
Oil; δppm 1.54 (3H, s), 2.05 (1H, d), 3.07 (1H, d), 3.15 (3H, s), 3.75 (2H, d), 4.02 (3H, s), 6.36 (1H, s),



7.21 (1H, m), 7.56 (2H, m)


396
Oil; δppm 1.70 (3H, s), 3.38 (1H, d), 3.56 (3H, s), 3.94 (1H, d), 4.29 (2H, m), 6.36 (1H, s),



7.35 (1H, d), 7.69 (1H, d)


397
Oil; δppm 0.95 (6H, d), 1.72 (3H, s), 2.01 (1H, m), 3.38 (1H, d), 3.56 (3H, s), 3.94 (1H, d),



4.07 (2H, m), 6.36 (1H, s), 7.35 (1H, d), 7.67 (1H, d)


398
Oil; δppm 1.72 (3H, s), 1.93 (4H, m), 3.37 (1H, d), 3.56 (3H, s), 3.81 (2H, m), 4.03 (1H, d),



4.16 (1H, m) 4.23 (2H, m), 6.36 (1H, s), 7.35 (1H, d), 7.67 (1H, d)









FORMULATION EXAMPLE (BASE ON 100% ACTIVE INGREDIENT (WEIGHT/WEIGHT %))
Example 14 35% Emulsifiable Concentrate

















Compound 6
35%



phosphorous acid
10%



ethoxylated triglyceride
15%



cyclohexanone
Make up to 100%









The phosphorous acid was dissolved in cyclohexanone, followed by addition of compound 6 and ethoxylated triglycerides to form clear solution.


Example 15 60% Wettable Powders

















Compound 43
60%



sodium dodecylsulphate
2%



sodium lignosulphonate
9%



kaolin
Make up to 100%









Compound 43, sodium dodecylsulphate, sodium lignosulphonate and kaolin are fully mixed, after smashing through ultrafine pulverizer to the required standard.


Example 16 60% Water Dispersible Granules















Compound 6
60%


Naphthalene sulfonate formaldehyde condensate
12%


N-methyl-N-oil acyl-bovine sodium
8%


Polyvinylpyrrolidone
2%


Carboxymethyl cellulose
2%


Kaolin
Make up to 100%









Compound 6 and other components are mixed and smashed, then kneaded together with water, added to the granulation 10-100 mesh machine for granulation, finally dried and sieved (at the scope screen).


Example 17 40% Suspension Concentrate

















Compound 55
40%



Glycol
10%



Nonylphenols polyethylene glycol ether
 6%



Lignin sulfonate
10%



Carboxymethyl cellulose
 1%



37% formaldehyde aqueous solution
0.2% 



75% of silicone oil water emulsion
0.8% 



water
Make up to 100%









Fully mixing compound 55 and other components, suspension concentrate can be obtained, and then any required concentration dilution can be obtained by diluting the above obtained concentrated suspension with water.


TEST OF BIOLOGICAL ACTIVITY
Example 18 Bioassay of Herbicidal Activity in Greenhouse

Determination of herbicidal activity of compounds of the present invention against weeds was carried out by the following procedures:


Seeds of monocotyledonous and dicotyledonous weeds were sown in nutrition soil in paper pot (7 cm diameter), covered with soil in 1 cm and grown in the greenhouse under good growth conditions (temperature, atmospheric humidity, water supply). The compounds of the present invention as emulsifiable concentrate, were applied in pre-emergence and post-emergence treatment by track sprayer (Engineer Research Ltd., pressure 1.95 kg/cm2, volume 500 L/hm2, track speed 1.48 km/h). Pre-emergence treatment was conducted after seeding 24 hours and post-emergence treatment was done when the respective weeds reached predetermined leaf stage (grass weed 2- to 3-leaf stage, broad-leaf weed 2- to 4-leaf stage), the state of growth of the respective weeds were visually observed to determine the growth inhibition rate(%) in accordance with the following evaluation standard.


Growth inhibition rate (%): 0=no discernible action: 100=all weeds dead or not emerged.


The results of general screening showed that compounds 4, 5, 6, 7, 8, 10, 15, 16, 17, 22, 23, 26, 35, 42, 43, 45, 46, 50, 54, 55, 66, 67, 83, 88, 90, 96, 99, 282, 284, 286, 290, 320, 321, 323, 324, 328, 329, 332, 333, 345, 366, 396, 397, 398 had a good pre-emergence and post-emergence herbicidal activity against broad-leaf weeds and grass weeds at 1000 g a.i./hm2.


Further screening results in Table 3.









TABLE 3







Herbcicidal Evaluation










Pre-emergence treatment













Setaria


Post-emergence treatment



















Zinnia


Abutilon


glauca


Echinochloacrus-


Zinnia


Abutilon


Setaria


Echinochloacrus-




Dose

elegans


theophrasti

(L.)

galli


elegans


theophrasti


glauca (L.)


galli



Compound
g a.i./hm2
Jacq.
Medic.
Beauv.
(L.) Beauv.
Jacq.
Medic.
Beauv.
(L.) Beauv.



















4
37.5
0
10
0
0
95
50
20
15



150
5
15
5
0
100
98
70
25



600
20
40
30
10
100
98
100
85


5
7.5




40
100
60
45



15.0




45
100
65
95



30.0




98
100
100
100



60.0




100
100
100
100



120.0




100
100
100
100


6
7.5




95
100
85
70



15.0




98
100
98
98



30.0




100
100
95
98



60.0




100
100
100
100



120.0




100
100
100
100



600
55
100
55
70
100
100
100
100


7
7.5




55
75
55
25



15.0




60
98
90
90



30.0




75
100
90
98



60.0




98
100
100
100



120.0




100
100
100
100


8
7.5




90
100
60
70



15.0




95
100
80
95



30.0




95
100
100
100



60.0




100
100
100
100



120.0




100
100
100
100


10
7.5




100
100
90
90



15.0




100
100
100
98



30.0




100
100
100
100



60.0




100
100
100
100



120.0




100
100
100
100


15
7.5




100
65
75
70



15.0




100
100
98
85



30.0




100
100
100
100



60.0




100
100
100
100



120.0




100
100
100
100


16
7.5




98
75
75
50



15.0




100
98
98
80



30.0




100
100
100
100



60.0




100
100
100
100



120.0




100
100
100
100


17
7.5




45
95
55
30



15.0




55
98
60
60



30.0




65
100
100
100



60.0




90
100
100
100



120.0




100
100
100
100



600
90
90
85
95
100
100
100
100


22
37.5
0
0
0
0
55
30
10
0



150
0
0
0
0
90
55
10
5



600
0
0
0
0
95
100
15
10


43
7.5
0
100
20
10
98
100
70
10



15
25
100
35
60
100
100
80
20



37.5
50
100
90
90
100
100
25
10



150
100
100
98
95
100
100
95
90



600
100
100
100
100
100
100
100
100


45
7.5
20
98
70
5
95
98
30
15



15
20
100
80
10
100
100
45
15



37.5
90
95
95
20
100
100
50
25



150
95
100
90
85
100
100
85
80



600
100
100
100
100
100
100
98
100


46
7.5
40
50
75
10
98
98
45
20



15
45
100
60
15
98
100
55
25



37.5
95
100
95
50
100
100
55
30



150
100
100
100
95
100
100
80
75



600
100
100
100
100
100
100
100
98


50
37.5
0
0
0
0
98
100
15
10



150
30
35
30
10
100
100
65
30



600
90
100
90
80
100
100
98
80


54
37.5
0
0
0
0
90
100
35
10



150
20
35
20
15
100
100
70
20



600
60
90
60
80
100
100
98
75


55
37.5
0
5
0
0
100
100
30
20



150
5
20
5
20
100
100
75
35



600
80
45
80
40
100
100
90
45


83
7.5
0
0
10
10
65
65
30
25



15
10
30
15
10
90
98
45
25



37.5
50
50
35
25
98
100
50
30



150
100
100
80
90
100
100
70
45



600
100
100
100
100
100
100
85
90


88
7.5
20
98
65
5
98
98
25
15



15
30
100
80
10
100
100
30
20



37.5
45
85
30
15
100
98
45
25



150
100
100
85
80
100
100
70
60



600
100
100
100
100
100
100
98
95


90
37.5
5
0
5
0
98
100
25
15



150
30
10
20
10
100
100
60
35



600
80
30
50
25
100
100
80
40


284
37.5
0
0
0
0
100
95
75
70



150
10
50
10
10
100
100
90
80



600
35
65
20
20
100
100
100
100


286
37.5
0
0
0
0
85
90
15
20



150
0
0
10
5
100
100
70
60



600
10
15
30
15
100
100
75
75


290
37.5
0
10
0
0
75
85
40
25



150
0
35
10
0
100
98
75
65



600
20
60
25
20
100
100
85
70


396
7.5




30
98
25
20



15.0




60
100
55
55



30.0




75
100
85
95



60.0




100
100
98
100



120.0




100
100
100
100


397
7.5




60
98
55
45



15.0




85
100
75
65



30.0




95
100
85
100



60.0




100
100
100
100



120.0




100
100
100
100


398
7.5




65
98
55
65



15.0




90
98
95
75



30.0




100
100
100
95



60.0




100
100
100
100



120.0




100
100
100
100


70%
7.5




45
100
10
0


Saflufenacil
15.0




50
100
10
0


WG
30.0




98
100
30
5



60.0




100
100
50
15



120.0




100
100
75
25





70% Saflufenacil WG is commercially available from BASF.


“—” mean no test






Example 19 Crop Safety Study in Greenhouse

Seeds of soybean, cotton, maize, wheat and rice were sown in nutrition soil in paper pot (9 cm diameter), covered with soil in 1 cm and grown in the greenhouse under good growth conditions (temperature, atmospheric humidity, water supply). The compounds of the present invention as emulsifiable concentrate, were applied in pre-emergence and post-emergence treatment by track sprayer (Engineer Research Ltd., pressure 1.95 kg/cm2, volume 500 L/hm2, track speed 1.48km/h). Pre-emergence treatment was conducted after seeding 24 hours and post-emergence treatment was done when the respective weeds reached predetermined leaf stage (soybean and cotton at 2- to 4-leaf stage and maize, wheat and rice at 3-leaf stage), the state of growth of the respective crops were visually observed to determine the safety in accordance with the following evaluation standard.


Safety rating scale (%): 0 means no damage to crops; 100 means to kill crops completely.


The results showed that wheat, maize and rice have good safety to compound 43, 45, 46, 83 at 7.5-37.5 g a.i./hm2 with pre-emergence and post-emergence application.


Example 20 Weed Spectrum Study in Greenhouse of Compound 6

The method is as example 18.









TABLE 4







Weed spectrum of compound 6
















Cyperus




Arthraxon







difformis


Cyperusglo


Digitaria


hispidus





L.

meratus L.


sanguinalis (L.)

(Thunb.)

Amaranthus




Dose
(4,5-leaf
(5-leaf
(4,5-leaf
Makino (3-leaf

retroflexus L.



Compound
g a.i./hm2
stage)
stage)
stage)
stage)
(height 10-15 cm)
















95%
7.5
30
80
80
60
90


Compound 6
15
60
80
90
85
98



30
90
90
100
90
100



60
95
100
100
100
100



120
100
100
100
100
100


70%
7.5
5
0
5
15
70


Saflufenacil
15
5
0
5
20
80


WDG
30
10
10
15
30
98



60
15
10
20
35
100



120
70
45
35
45
100









Example 21 Field Trial

The field trial was conducted in an orchard located at Liaoyang city, Liaoning province, China; the orchard planted mainly apple trees and almond trees, plum trees and pear trees as well, weeding control were conducted three times one year by application of paraquat. Weeds were distributed uniformity and moderate density, mainly of broad-leaf weeds including Conyza canadensis (L.)Cronq., Sonchus brachyotus DC., Polygonum aviculare L., Humulus scandens (Lour.) Merr., Ixeridium sonchifolium (Maxim.) Shih, Galium aparine L. var. tenerum Gren.et (Godr.) Rebb., Rumex japonicus Houtt. and Metaplexis japonica (Thunb.) Makino, partly of grass weed was Digitaria sanguinalis (L. ) Scop., average height range was between 30 and 40 cm. sprayer was knapsack hand-operated sprayer(AGROLEX HD400) produced by AGROLEx PTE Ltd., spray volume was 675 L/hm2, processing date was Jul. 3, 2015. On the 15th day after application, weeds were visually observed to determine the growth inhibition rate(%).









TABLE 5







Field trail of compound6 for control weed in non-cultivated land













Growth






inhibition

Total growth




rate (%) of
Growth inhibition
inhibition



Dose
grass
rate (%) of
rate (%)


Compound
g a.i./hm2
weed
broad-leaf weeds
of weeds














95%
60
61.7
85.0
81.7


Compound 6
120
71.7
93.3
91.7



180
83.3
94.3
91.7



240
88.3
97.0
93.3



300
94.3
92.7
98.7


70%
60
25.0
75.0
58.3


Saflufenacil






WDG






20% Paraquat
375
97.7
99.3
96.7


AS





Paraquat: ®gramoxone20% AS (Syngenta)





Claims
  • 1. A kind of uracil compounds containing isoxazoline ring having general formula (I):
  • 2. The compounds according to the claim 1, characterized in that wherein general formula (I): R1 is selected from C1-C4haloalkyl;R2 is selected from C1-C4alkyl or C1-C4haloalkyl;R3, R4, R5, R6 are selected from H, halogen, C1-C6alkyl or C1-C6alkoxy;R7 is selected from H or C1-C6alkyl;R8 is selected from H, C1-C6alkyl, CO2R11 or CH2OR12;R9 is selected from H, CN, C1-C6alkyl, C1-C6haloalkyl, CO2R11, CH2OR12, CH2NR13R14 or CONR13R14;
  • 3. The compounds according to the claim 2, characterized in that wherein general formula (I): R1 is CF3;R2 is CH3;R3, R4, R5, R6 are selected from H, halogen or C1-C4alkyl;R7 is selected from H or C1-C4alkyl;R8 is selected from H, C1-C4alkyl, CO2R11 or CH2OR12;R9 is selected from H, CN, C1-C4alkyl, C1-C4haloalkyl, CO2R11, CH2OR12, CH2NR13R14 or CONR13R14;R10 is selected from H, C1-C4alkyl, C1-C4haloalkyl, phenyl, or phenyl substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy, C1-C4haloalkoxy, C1-C4alkoxycarbonyl, C1-C4alkylthio or C1-C4alkylsulfonyl;R11 is selected from H, C1-C4alkyl, C1-C4haloalkyl, C3-C4alkenyl, C3-C4alkynyl, C1-C4alkoxyC1-C4alkyl, C1-C4alkoxycarbonylC2-C3alkyl, unsubstituted or substitutued following groups: benzyl, furanmethyl, or tetxahydxofuranmethyl, which is mutually independently optionally substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C4alkyl or C1-C4haloalkyl;R12 is selected from H, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxycarbonyl, C1-C4alkylcarbonyl, C1-C4haloalkylcarbonyl, C3-C6cycloalkylcarbonyl, C3-C6halocycloalkylcarbonyl, C1-C4alkylsulfonyl, C1-C4haloalkylsulfonyl, C1-C3alkylaminosulfonyl, di(C1-C3)alkylanimosulfonyl, C1-C3alkylaminocarbonyl, di(C1-C3)alkylaminocarbonyl, di(C1-C3)alkylaminothiocarbonyl, C1-C2alkylthioC2-C4alkylcarbonyl; R12 is also selected from unsubstituted or substituted following groups: phenylC1-C2alkyl, phenylcarbonyl, phenylC1-C2alkylcarbonyl, phenoxyC1-C2alkylcarbonyl, phenylC2-C4alkenylcarbonyl, thiophenylcarbonyl, pyrazolcarbonyl or quinolinecarbonyl, which is mutually independently optionally substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy, C1-C4haloalkoxy, C1-C4alkoxycarbonyl, C1-C4alkylthio, C1-C4alkylsulfonyl, or phenoxy substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy or C1-C4haloalkoxy;R13R14 are selected from H, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxycarbonylC1-C4alkyl; or R13 joined together with R14 through N to form five or six membered ring.
  • 4. The compounds according to the claim 3, characterized in that wherein general formula (I): R1 is CF3;R2 is CH3;R3, R4, R5, R6 are selected from H, F, Cl or CH3;R7 is selected from H or CH3;R8 is selected from H, CH3, CO2R11 or CH2OR12;R9 is selected from H, CN, CH3, C2H5, CH2Cl, CH2Br, CO2R11, CH2OR12, CH2NR13R14 or CONR13R14;R10 is selected from H, C1-C4alkyl, C1-C4haloalkyl, phenyl, or phenyl substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy or C1-C4haloalkoxy;R11 is selected from H, C1-C4alkyl, C1-C4haloalkyl, allyl, propargyl, C1-C3alkoxyC1-C3alkyl, C1-C4alkoxycarbonylC2-C3alkyl, unsubstituted or substituted following groups: benzyl, furanmethyl, or tetrahydrofuranmethyl, which is mutually independently optionally substituted with 1-4 substitutents selected from halogen, CN, NO2 or C1-C4alkyl;R12 is selected from H, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxycarbonyl, C1-C4alkylcarbonyl, C1-C4haloalkylcarbonyl, C3-C6cycloalkylcarbonyl, C1-C4alkylsulfonyl, C1-C4haloalkylsulfonyl, di(C1-C3)alkylaminosulfonyl, C1-C3alkylaminocarbonyl, di(C1-C3)alkylaminocarbonyl, di(C1-C3)alkylaminothiocarbonyl, C1-C2alkylthioC2-C4alkylcarbonyl; R12 is also selected from unsubstituted or substituted following groups: phenylcarbonyl, phenylC1-C4alkylcarbonyl, phenoxyC1-C2alkylcarbonyl, thiophenylcarbonyl, pyrazolcarbonyl or quinolinecarbonyl, which is mutually independently optionally substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy, C1-C4haloalkoxy, C1-C4alkoxycarbonyl, C1-C4alkylthio, C1-C4alkylsulfonyl or 2-chloro-4-trifluoromethyl-phenoxy;R13, R14 are selected from H, C1-C4alkyl, C1-C4haloalkyl, C1C4alkoxycarbonylC1-C4alkyl; or R13 joined together with R14 through N to form five or six membered ring.
  • 5. The compounds according to the claim 4, characterized in that wherein general formula (I): R1 is CF3;R2 is CH3;R3, R4 are selected from H, F, Cl or CH3;R5, R6 are H;R7 is selected from H or CH3;R8 is selected from H, CH3, CO2R11 or CH2OR12;R9 is selected from H, CN, CH3, C2H5, CH2Cl, CH2Br, CO2R11, CH2OR12 or CONR13R14;R8, R9 are not selected from CO2R11 or CH2OR12 at the same;R10 is selected from H, CH3, C2H5, CF3, CHF2, phenyl, or phenyl substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1C4alkoxy or C1-C4haloalkoxy;R11 is selected from H, CH3, C2H5, CH3CH2CH2, CH3CH2CH2CH2, (CH3)2CH, (CH3)2CHCH2, (CH3)3C, CF3CH2, allyl, propargyl, CH3OCH2CH2, C2H5OCH2CH2, CH3CO2CH2CH2 or tetrahydrofuranmethyl;R12 is selected from H, C1-C4alkoxycarbonyl, C1-C4alkylcarbonyl, C1-C4haloalkylcarbonyl, C3-C6cycloalkylcarbonyl, C1-C4alkylsulfonyl, C1-C4haloalkylsulfonyl, di(C1-C2)alkylaminosulfonyl, C1-C2alkylaminocarbonyl, di(C1-C3)alkylaminocarbonyl, di(C1-C2)alkylaminothiocarbonyl, C1-C2alkylthioC2-C4alkylcarbonyl; R12 is also selected from unsubstituted or substituted following groups: phenylcarbonyl, phenylC1-C2alkylcarbonyl, phenoxyC1-C2alkylcarbonyl, thiophenylcarbonyl or quinolinecarbonyl, which is mutually independently optionally substituted with 1-4 substitutents selected from halogen, CN, NO2, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy, C1-C4haloalkoxy, C1-C4alkoxycarbonyl, C1-C4alkylthio, C1-C4alkylsulfonyl or 2-chloro-4-trifluoromethyl-phenoxy;R13 is selected from H, C1-C4alkyl or C1-C4haloalkyl;R14 is selected from H, C1-C4alkyl or C1-C4alkoxycarbonylC1-C4alkyl;or R13 joined together with R14 through N to form five or six membered ring.
  • 6. The compounds according to the claim 5, characterized in that wherein general formula (I): R1 is CF3;R2 is CH3;R3, R4 are selected from H, F or Cl;R5, R6 are H;R7 is selected from H or CH3;R8 is selected from H, CH3, CO2R11 or CH2OR12;R9 is selected from H, CN, CH3, C2H5, CH2Cl, CH2Br, CO2R11, CH2OR12 or CONR13R14;R8, R9 are not selected from CO2R11 or CH2OR12 at the same;R10 is selected from H, CH3 or C2H5;R11 is selected from H, CH3, C2H5, CH3CH2CH2, CH3CH2CH2CH2, (CH3)2CH, (CH3)2CHCH2, (CH3)3C, CF3CH2, allyl, propargyl, CH3OCH2CH2, C2H5OCH2CH2, CH3CO2CH2CH2 or tetrahydrofuranmethyl;R12 is selected from H, C1-C4alkylcarbonyl, C1-C4haloalkylcarbonyl, C3-C6cycloalkylcarbonyl, C1-C4alkylsulfonyl, C1-C4haloalkylsulfonyl, di(C1-C2)alkylaminosulfonyl, di(C1-C3)alkylaminocarbonyl, di(C1-C2)alkylaminothiocarbonyl, C1-C2alkylthioC2-C4alkylcarbonyl, phenylC1-C2alkylcarbonyl, 2-methyl-4-chlorophenoxyacetyl, 2,4-dichlorophenoxyacetyl or thiophenylcarbonyl;R12 is also selected from
  • 7. The compounds according to the claim 6, characterized in that wherein general formula (I): R1 is CF3;R2 is CH3;R3, R4 are selected from H, F or Cl;R5, R6, R7, R8 are H;R9 is selected from H, CN, CH3, C2H5, CH2Cl, CH2Br, CO2R11, CH2OR12 or CONR13R14;R10 is selected from H, CH3 or C2H5;R11 is selected from H, CH3, C2H5, CH3CH2CH2, CH3CH2CH2CH2, (CH3)2CH, (CH3)2CHCH2, (CH3)3C, CF3CH2, allyl, propargyl, CH3OCH2CH2, C2H5OCH2CH2, CH3CO2CH2CH2 or tetrahydrofuranmethyl;R12 is selected from H, C1-C4alkylcarbonyl, C1-C4haloalkylcarbonyl, cyclopropylcarbonyl, C1-C4alkylsulfonyl, C1-C4haloalkylsulfonyl, di(C1-C2)alkylaminosulfonyl, di(C1-C3)alkylaminocarbonyl, di(C1-C2)alkylaminothiocarbonyl, C1-C2alkylthioC2-C4alkylcarbonyl, phenylC1-C4alkylcarbonyl, 2-methyl-4-chlorophenoxyacetyl, 2,4-dichlorophenoxyacetyl or thiophenylcarbonyl;R12 is also selected from
  • 8. A process for the preparation of a kind of uracil compounds containing isoxazoline ring having general formula (I), which process comprises reacting amino-compounds of the formula (III)
  • 9. A process for the preparation of amino-compounds of the formula (III)
  • 10. A method of controlling weeds which comprises applying the compound having general formula (I) according to claim 1.
  • 11. A herbicidal composition comprising the compound having general formula (I) of claim 1 as an active ingredient, wherein the weight percentage of the active ingredient in the composition is from 0.1-99%.
  • 12. A method of controlling weeds which comprises applying a herbicidal composition according to claim 11.
Priority Claims (1)
Number Date Country Kind
201410781642.X Dec 2014 CN national
PCT Information
Filing Document Filing Date Country Kind
PCT/CN2015/097223 12/14/2015 WO 00